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THE BLIND MEN  
AND THE ELEPHANT 
 
It was six men of Indostan 
To learning much inclined, 
Who went to see the Elephant 
(Though all of them were blind), 
That each by observation 
Might satisfy his mind. 
 
The First approach'd the Elephant, 
And happening to fall 
Against his broad and sturdy side, 
At once began to bawl: 
"God bless me! but the Elephant 
Is very like a wall!" 
 
The Second, feeling of the tusk, 
Cried, -"Ho! what have we here 
So very round and smooth and sharp? 
To me 'tis mighty clear 
This wonder of an Elephant 
Is very like a spear!" 
 
The Third approached the animal, 
And happening to take 
The squirming trunk within his hands, 
Thus boldly up and spake: 
"I see," quoth he, "the Elephant 
Is very like a snake!" 
 
The Fourth reached out his eager hand, 
And felt about the knee. 
"What most this wondrous beast is like 
Is mighty plain," quoth he, 
"'Tis clear enough the Elephant  
Is very like a tree!" 
 
The Fifth, who chanced to touch the ear, 
Said: "E'en the blindest man 
Can tell what this resembles most; 
Deny the fact who can, 
This marvel of an Elephant 
Is very like a fan!" 
 
The Sixth no sooner had begun 
About the beast to grope, 
Then, seizing on the swinging tail 
That fell within his scope, 
"I see," quoth he, "the Elephant 
Is very like a rope!" 
 
And so these men of Indostan 
Disputed loud and long, 
Each in his own opinion 
Exceeding stiff and strong, 
Though each was partly in the right, 
And all were in the wrong! 
 
JG Saxe (1816-1887), from a hindoo fable 
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ABSTRACT 
 
Epilepsy is much more common in individuals with autism than in the general population. The 
extent to which epilepsy influences the outcome of autism is poorly understood. Many children 
with medically intractable epilepsy have neurodevelopmental disorders, including autism. The 
objective of this study was to gain further insight into the co-occurrence of epilepsy and autism.  
 
In a population-based follow-up study of 120 individuals with autism diagnosed in childhood, 
108 were reassessed at ages 17-40 years. The majority had autism and mental retardation 
(MR). The carers of 42/43 with a history of epilepsy were interviewed, and medical charts 
were reviewed. Epilepsy onset was most common in the first years of life but also occurred in 
adults. Partial seizures dominated and seizure frequency had a great impact on the individuals’ 
lives. Epilepsy remitted in 16%. Severe MR and autism were significantly associated with 
epilepsy, especially in females. The cognitive level and the adaptive behaviour level were 
significantly lower in the epilepsy group than in the non-epilepsy group. 
 
The medical charts of 16 children undergoing temporal lobe resections were reviewed and the 
histopathological specimens were re-evaluated. Psychopathology was found in 12. Five had 
autism before and after surgery, one of whom became seizure free, and in three there was a 
positive behavioural change. Malformations of cortical development were associated with 
worse seizure outcome and were more common in children with psychopathology. 
 
A neuropsychiatric examination and assessments of psychosocial functioning and IQ were 
performed at baseline and at 2-year follow-up to assess individual outcome in (i) 25 children 
undergoing epilepsy surgery, and in (ii) eight children with autism and intractable epilepsy 
treated with vagus nerve stimulation (VNS).  
In study (i) psychopathology (mainly autism and ADHD) was present in 17 of the children at 
some point and contributed in a major way to the psychosocial dysfunction in affected children. 
Among the children with preoperative psychopathology, one was without a diagnosis after 
surgery. The IQ level before surgery predicted the IQ level after surgery in most cases. Seven 
had autism before and after surgery, and the parents reported a positive behavioural change in 
six. Psychosocial functioning was mainly stable in autism, except in one child who became 
seizure free and improved in psychosocial functioning and in one child who deteriorated.   
In study (ii) no one had a reduced seizure frequency after two years of VNS, autism remained 
and changes concerning intellectual abilities and psychosocial functioning were minor in most 
subjects. The parents of three children reported a positive change in social interactive abilities, 
and those of one child reported a negative change.  
 
In conclusion, the follow-up study of young adults with autism showed high rates of epilepsy, 
poor prognosis, and low remission rates. Neuropsychiatric disorders were common at baseline 
and two years after epilepsy surgery. A diagnosis of autism in children with intractable epilepsy 
remained after surgical intervention. Symptomatic improvement is not always the same as 
functional improvement. The main aim of epilepsy surgery is seizure control, regardless of 
whether or not there is co-existing psychopathology.  
 
Key words: epilepsy, autism, epilepsy surgery, VNS, children, treatment outcome, 
psychopathology, cognition 
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INTRODUCTION 
 
Autism is one of the neurodevelopmental disorders, as are eg mental retardation (MR), speech 
and language disorders and cerebral palsy (CP). They are heterogeneous conditions but have in 
common the long-term effects of delay and disability, caused by damage to the neurological 
processes responsible for developmental functioning. Neurodevelopmental disorders can be 
caused by many different underlying disorders and pathological processes. The neuropsychiatric 
disorders are closely related to the neurodevelopmental disorders and can be agreed on and 
communicated to others by reference to criteria such as those of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) (American Psychiatric Association (APA) 1994) or the 
International Classification of Diseases (ICD) (World Health Organization (WHO) 1993). 
Taylor has pointed out that diagnostic schedules bring a certain level of understanding for 
clinical purposes and can suggest certain courses of action, but that our diagnostic categories are 
weak with which to do science (Taylor 2003).  If a “medical” diagnosis is made very early in a 
child with a neurodevelopmental disorder, such as “epilepsy” or “tuberous sclerosis”, this 
medical or aetiological diagnosis will often take precedence and the child will not be referred for 
further examinations. Psychopathology is more common in children with epilepsy than in the 
general population, but often remains undiagnosed (Rutter et al. 1970; Davies et al. 2003).  
 
Neurodevelopmental disorders often occur together, but our knowledge of the exact prevalence 
and public health implications is often hindered by a lack of population-based surveillance data 
(Kirby 2002), as well as by changes over time in definitions and classifications. The extent to 
which epilepsy influences the outcome of autism is poorly understood. This thesis focuses on the 
relationship between autism and epilepsy from two perspectives: epilepsy in individuals with 
autism, and autism and other neuropsychiatric disorders in children who go through surgical 
interventions for medically intractable epilepsy.  
 
 
BACKGROUND 
 
Epilepsy 
 
Epilepsy is defined as two or more epileptic seizures, unprovoked by any immediate identifiable 
cause (the International League Against Epilepsy (ILAE), 1997) and excludes seizures that are 
only neonatal. A new definition has been proposed and is debated (Fisher et al. 2005). The 
prevalence is 0.5-1% in the childhood population and the aetiology is unknown in 55-75% of 
cases (Cowan 2002). An epileptic seizure is a transient clinical event that results from abnormal 
activity of synchronized, more or less extensive populations of cerebral neurons and this 
abnormal activity results in paroxysmal disorganization of one or several brain functions 
(Aicardi 1998). Epilepsy is classified according to seizure type and syndrome (ILAE 1981 and 
1989). The current classification system is debated (Loddenkemper et al. 2005; Engel 2006). A 
diagnosis of epilepsy is typically based on the history from witnesses in combination with the 
results from EEG and more seldom from video-EEG recordings. 
 
Epilepsy and intellectual ability 
The severity of mental retardation (MR) in terms of IQ exerts a major influence on 
development and adjustment, and the presence of any major physical disability in MR has 
substantial bearing on outcome (O'Brien 2001).  Epilepsy is a common disorder among 
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individuals with MR (Steffenburg et al. 1995). In European population-based studies about one 
out of five with MR has epilepsy (Forsgren et al. 1990), and 31 % of children with epilepsy 
have MR (Sillanpää 1992).  According to the DSM-IV (APA 1994) the criteria for MR are: 
 
 
A. Significantly sub average intellectual functioning: an IQ of approximately 70 or below on an 
individually administered IQ-test (for infants, a clinical judgement of significantly sub average 
intellectual functioning). 
B. Concurrent deficits or impairments in present adaptive functioning (i.e., the person’s 
effectiveness in meeting the standards expected for his or her cultural group) in at least two of 
the following areas: communication, self-care, home-living, social/interpersonal skills, use of 
community resources, self-direction, functional academic skills, work, leisure, health, and safety. 
C. The onset is before 18 years. 
 
 
There are different degrees of severity: mild MR (IQ 50-55 to approximately 70), moderate MR 
(IQ 35-40 to 50-55), severe MR (IQ 20-25 to 35-40) and profound MR (IQ <20-25). In 
research, MR is often divided into only two different degrees of severity: mild MR (MMR) (IQ 
50-69) and severe MR (SMR) (IQ<50).  
 
At least one out of ten children with MMR (Hagberg et al. 1981) will have epilepsy, and among 
those with SMR, approximately one out of three (Gustavsson et al. 1977). An earlier age of 
onset of seizures is associated with poorer cognitive function (Hermann et al. 2008). Recurrent 
seizures may represent a considerable risk for intellectual decline in children (Bjørnaes et al. 
2001; Freitag & Tuxhorn 2005). 
 
Epilepsy and psychopathology 
In an often quoted neuropsychiatric study in childhood, Rutter and co-workers reported that 7% 
of children in the general population had psychopathology compared with 12% of children with 
physical, non-neurological disorders, 29% of children with uncomplicated epilepsy, and 58% of 
children with structural brain anomalies (Rutter et al. 1970). Thirty years later another 
population-based study reported strikingly similar results (Davies et al. 2003). In a recent critical 
review, studies identifying factors associated with behavioural and psychiatric co-morbidities in 
paediatric epilepsy were placed in two categories: illness-related variables and psychosocial 
variables (Austin & Caplan 2007). Concerning the illness-related variables (seizure frequency 
and control; type of epilepsy; age of onset; duration of epilepsy and antiepileptic drugs (AEDs)) 
the authors stressed that these variables are associated with co-morbid cognitive and linguistic 
deficits, which in turn contribute to behaviour difficulties, especially in children with MR, 
intractable epilepsy and early onset epilepsy. As regards psychosocial variables it was concluded 
that greater family stress, fewer family adaptive resources, more negative perceptions about 
epilepsy, more negative parent-child interactions, and poorer family adjustment were associated 
with more child behaviour problems.  
 
Older studies suggested that the type of epilepsy and left lateralization of epileptiform activity 
were associated with more severe behavioural disturbances (Rutter et al. 1970; Lindsay et al. 
1979). More recent studies indicate, however, that there is no association between type of seizure 
disorder and type of psychopathology in children with epilepsy and normal IQ, and that children 
with temporal lobe epilepsy do not have more disturbances except psychosis (Caplan & Austin 
2000). The most often reported psychiatric disorders in children with epilepsy are disruptive 
behaviour disorders (DBD), (attention-deficit/hyperactivity disorder (ADHD), oppositional 
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defiant disorder (ODD) and conduct disorder) and emotional disorders (depression and anxiety) 
which are found in about one fourth to one third (Dunn & Austin 2008). The DSM-IV 
discriminates three subtypes of ADHD: the predominantly inattentive type (ADHD-I), the 
predominantly hyperactive-impulsive type (ADHD-H) and the combined type (ADHD-C). Co-
morbidity is common with eg emotional disorders and ODD. In children without epilepsy 
ADHD is more common in boys and most often of the combined type. In children with epilepsy 
the inattentive type seems to be as common as the hyperactive-impulsive type, and at least as 
common in girls as in boys (Dunn et al. 2003). Autism is often co-occurrent with epilepsy in 
children with MR. In a population-based study on children with MR and active epilepsy, a 
psychiatric diagnosis was found in 59%, the majority having autism (38%) (Steffenburg et al. 
1996).  
 
Prognosis 
The prognosis of seizure disorders varies widely. Childhood onset epilepsy often remits. In a 
population-based study by Camfield et al. (1993), 55% of childhood epilepsy cases remitted. 
Predictors of remission have been shown to be the occurrence of only one type of seizure, 
normal mental and neurological development and the absence of a detectable cause (Brorson & 
Wranne 1987). There is an increased mortality in epilepsy at all ages, with the highest mortality 
rates in cohorts of persons with MR and intractable epilepsy (Sperling et al.1999). Although the 
majority of patients with epilepsy in childhood will be free of seizures as adults, there is still an 
increased risk for social and educational problems, as well as an increased risk of premature 
death (Sillanpää et al. 1998).  
 
 
Intractable epilepsy 
 
About 20-30% of children with epilepsy still have seizures in spite of medication. The figures 
vary, because the definitions of intractability differ (Huttenlocher 1994). Medical intractability 
can be defined as a situation where a person continues to have seizures despite accurate epilepsy 
diagnosis and appropriately selected and dosed AEDs. Strong predictors for intractability are 
other signs of neurodeficits such as MR. In comparison to children with epilepsy and MMR, 
additional disabilities such as CP, visual impairment, communication and behavioural problems 
are more common in children with SMR and epilepsy, as are intractable seizures (Airaksinen et 
al. 2000).  
 
The catastrophic epilepsy disorders begin in children younger than 5 years, are difficult to 
control and are strongly associated with MR. A child with intractable epilepsy may have 
additional impairments due to the underlying brain dysfunction (also causing epilepsy) or due to 
epilepsy induced dysfunction. Hermann & Seidenberg (1995) presented the concept that an 
epileptogenic cortex may adversely affect the extratemporal regions that mediate executive 
function abilities, thereby resulting in performance deficits, including neuropsychiatric co-
morbidities. In the group of children with drug-resistant epilepsy not eligible for epilepsy 
surgery there are many with severe cognitive impairments and other disabilities (Besag 2002; 
Devinsky 2003).  
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Treatment 
Treatment of intractable epilepsy is multiprofessional and includes pharmacological treatment, in 
some cases epilepsy surgery and - if epilepsy surgery is not possible - ketogenic diet or vagus 
nerve stimulation (VNS).  
 
Epilepsy surgery 
Epilepsy surgery may be considered in children and adults with partial seizures or generalized 
seizures that are caused by a localizable cortical abnormality. The pre-operative evaluation aims 
at analyzing potential benefits and risks of the procedure and is therefore comprehensive and 
multidisciplinary. History taking and neurological examination, video-EEG with surface 
electrodes and structural magnetic resonance imaging (MRI) are used to establish the presence of 
a zone of cortical abnormality. Sometimes additional investigations may be required in case of 
discordant findings, or if the seizure focus is close to functionally important cortex. Additional 
investigations may include positron emission tomography (PET)/single-photon emission com-
puted tomography (SPECT), functional MRI (fMRI), magnetoencephalography (MEG) and 
video-EEG monitoring using subdural or depth-electrodes. Virtually all epilepsy surgery centres 
include a comprehensive neuropsychological assessment before and after surgery. This 
assessment can provide information about areas of brain dysfunction and relate it to the 
epileptogenic area, it can identify the risks to speech and other functions related to surgery and 
evaluate cognitive outcome. A neuropsychiatric assessment should be included but is not routine 
at all centres. 
 
There are two main types of surgical procedures for epilepsy – resective and disconnective 
procedures; a resective procedure aims at removing the region causing seizures, while the 
disconnective procedure is used to limit the spread of seizure activity.  
 
Histopathological findings 
The most common histopathological findings reported after temporal lobe resections (TLR) are 
hippocampal sclerosis, tumours (often specific low-grade tumours), vascular malformations and 
malformations of cortical development (MCD) (Zentner et al. 1995). Pathology in 50 preschool 
children undergoing different epilepsy surgery procedures, showed focal cortical dysplasia (a 
kind of MCD) in 44%, tumours in 26% and mixed in 30 % (encephalitis, hypoxic-ischemic 
damage, tuberous sclerosis, hippocampal sclerosis with microdysgenesis and hemi-
megalencephaly) (Freitag & Tuxhorn 2005). 
  
Major MCD are usually classified according to distinct macroscopical patterns, whereas minor 
malformations such as microdysgenesis are classified according to specific microscopical 
features (Mischel et al. 1995; Nordborg et al. 1999), for which different investigators have used 
different diagnostic criteria. Focal dysplasia of the cerebral cortex in epilepsy surgery candidates 
was described by Taylor et al. in 1971. It has been difficult to achieve a uniform terminology 
and there is an on-going debate (Palmini et al. 2004). Dual or multiple aetiology is not always 
reported in epilepsy surgery series (Vinters et al. 1993). Patients are often classified according to 
the main histopathological or neuroradiological feature in predetermined groups. Eriksson et al. 
(1999), however, presented all the histopathological diagnoses in 139 children and adults from 
the Gothenburg epilepsy surgery series 1987-95. MCD and atrophic-gliotic lesions were the 
most common findings; MCD were found in 56% of the children, and in 23% of the adults.  
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Outcome  
Resective surgery means taking away dysfunctional brain tissue, but to rule out that the 
procedure creates or aggravates a dysfunction, epilepsy candidates are carefully monitored 
before and after surgery. In an editorial commentary Taylor et al. pointed out that new measures 
of outcome are needed and that different outcome categories can be outlined based on the 
probability of success (Taylor et al. 1997). Most surgical procedures aim at seizure freedom 
especially in patients with defined lesions. However, in children with catastrophic epilepsy, the 
aim may be to reduce seizures in order to prevent an intellectual and behavioural decline. Better 
seizure outcome after surgery is reported in patients with vascular malformations and tumours, 
and worse outcome in patients with MCD and gliosis (Zentner et al. 1995). Not only the 
histopathological diagnosis, but also the localization of the lesion and the surgical procedure 
have implications for outcome. Hemispherectomies and TLR carry the best prognosis with 43-
79% and 58-78% seizure free children, respectively (Spencer & Huh 2008). Complex partial 
seizures of temporal lobe origin are the most common type of intractable seizures in adults and 
have the most successful outcome after surgical treatment. The results are reported to be equally 
good in some paediatric series, which include only selected patients without MR (Wyllie et al. 
1998; Mohamed et al. 2001). Temporal lobe epilepsy is responsible for less than one third of 
surgical resections in children and most paediatric series also include extratemporal and 
multilobar resections. There are several studies reporting good results of TLRs, but fewer studies 
evaluating the effects of extratemporal resections (Sinclair et al. 2004).  
 
The only randomized controlled trial of surgery for intractable temporal lobe epilepsy in 
candidates older than 16 years without MR showed that surgery is superior to prolonged medical 
therapy, concerning freedom from seizures and better quality of life (Wiebe et al. 2001). In the 
adult population it has until recently been assumed that patients with MR are bad candidates for 
epilepsy surgery. The belief is that their neurodeficit means that the epileptogenic zone is not 
localized enough for resection, or that a resection will result in worsened cognitive dysfunction. 
This has been challenged by Bjørnæs (2004), showing a good seizure outcome after resective 
surgery in adult patients with focal epilepsy and IQ<70, provided that the operation was done 
relatively shortly after the onset of epilepsy. The possibility of surgical treatment of medically 
intractable epilepsy in individuals with MR should be considered. In a recent follow-up study on 
resective epilepsy surgery in Sweden 1990 to 1999, 72 out of 448 patients (including children) 
had IQ<70. IQ was shown to be an independent predictor of seizure freedom: 22% in the IQ<50 
group, 37% in the IQ50-69 compared with 61% in the IQ≥ 70 group (Malmgren et al. 2008). 
When seizure outcome was related to histopathological diagnoses, the lesional cases had the best 
outcome across all three groups.  
 
Stability concerning IQ is the main postoperative result at group level in most studies on 
cognitive effects of temporal lobe epilepsy surgery in adults (Engman et al. 2001; Baxendale 
2008) and in children (Adams et al. 1990; Szabo et al. 1998), but there is individual 
heterogeneity. In pre-school children a catch-up development may occur, but only in seizure free 
patients (Freitag & Tuxhorn 2005). Intractable seizures seem to have more serious cognitive 
consequences in children than in adults and this has been suggested to depend on the 
vulnerability of intellectual abilities during the rapid development in childhood (Bjørnæs et al. 
2001). Development is partly based on the continuous experiences of the child, including normal 
options for learning and interacting.  
 
Little is known about the effects of epilepsy surgery on psychiatric disorders in children, 
although psychopathology is common in epilepsy surgery candidates (Taylor et al. 1999; 
McLellan et al. 2005). The largest published follow-up study addressing effects on 
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psychopathology in children undergoing TLRs for intractable epilepsy is a case-note review of 
performed neuropsychiatric assessments at baseline and at least one year after surgery 1992-
1998 in the Epilepsy Surgery Programme at Great Ormond Street Hospital for Children in 
London (McLellan et al. 2005). Reports of behavioural outcome after surgery often rely on 
neuropsychological observations, parental questionnaires or anecdotal information without 
clinical neuropsychiatric assessment before surgical intervention. There are positive reports on 
the developmental and behavioural outcome after epilepsy surgery in children (Asarnow et al. 
1997; Lendt et al. 2000; Freitag & Tuxhorn 2005), but there are also less favourable reports 
(McLellan et al. 2005; Mikati et al. 2008; Elliott et al. 2008).  
 
Vagus nerve stimulation (VNS) 
VNS is a palliative approach when epilepsy surgery is not possible (Wheless & Maggio 2002). A 
pulse generator is implanted below the left clavicle, electrodes are tunnelled to the left cervical 
vagus nerve and the stimulator settings are externally programmed. There are some major issues 
to be considered (Schachter 2002); there are no precise indications and we do not know the exact 
mechanism of action or optimal stimulation parameters. There are costs and, even though minor, 
surgical risks involved. More than 50 % seizure reduction is reported in 45% to 53% of children 
in the two largest series (Helmers et al. 2001; Murphy et al. 2003). Duration of reported outcome 
varies. Most studies on VNS effects are retrospective and there are no randomized controlled 
studies in children. There have been reports on positive effects on quality of life and behaviour 
with VNS, both in patients with improved seizure situation and in those without (Lundgren et al. 
1998; Valencia et al. 2001; Hallböök et al. 2005). In a prospective study on 16 children there 
were positive effects on behaviour and some other quality of life parameters independent of 
seizure control at 6-month follow-up, but these effects did not persist at follow-up two years 
later (Aldenkamp et al. 2001 and 2002).  
  
Autism 
 
The definitions of autism, or pervasive developmental disorder (PDD) according to the DSM-IV 
(APA 1994) or the ICD-10 (WHO 1993), include impairment and disability in three broad areas: 
social reciprocal interaction abilities, reciprocal communicative abilities, and behaviour, 
including a narrow range of stereotypic behaviours, activities and interests. In this thesis the term 
“autism” will be used synonymously with PDD. The term “autism spectrum disorders” is 
synonymous with the term PDD and includes the diagnoses autistic disorder (AD), Rett 
syndrome, disintegrative disorder, Asperger syndrome and PDD not otherwise specified (PDD-
NOS), roughly equivalent to the terms “atypical autism” and “autistic-like conditions” (ALC). 
The ICD-10 and DSM-IV definitions of AD (Table 1) are conceptually identical and facilitate 
research and clinical services (Volkmar et al.1994).  
 
There is a debate regarding the delineation of PDD-NOS (DSM-IV) and atypical autism (ICD-
10), since these diagnoses do not have operationalized diagnostic criteria making it difficult to 
compare data across research groups. Buitelaar et al. have suggested a scoring rule based on a 
short set of seven ICD-10/DSM-IV criteria with a cut-off of at three items and one social 
interaction item set as mandatory (Buitelaar et al. 1999). Gillberg has suggested that at least four 
of the 12 DSM-IV criteria for AD should be met for a diagnosis of atypical autism/PDD-NOS, 
including two criteria for qualitative impairment in social interaction (Billstedt et al. 2005).  
Since the criteria for PDD diagnoses are descriptive, the importance of a multidisciplinary 
assessment must be stressed. Combining information from multiple sources is essential. 
Diagnostic decision-making is straightforward if the clinical impression is consistent with the 
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results from standardized methods of collecting information with eg the Diagnostic Interview for 
Social and Communication Disorders (DISCO) (Wing et al. 2002) or the Autism Diagnostic 
Interview-Revised (ADI-R) (Rutter et al. 2003) in combination with a semistructured 
observation, like the Autism Diagnostic Observation Schedule (ADOS) (Lord et al. 2000), (Risi 
et al. 2006). 
 
 
Table 1. The diagnostic criteria for autistic disorder according to the DSM-IV 
_____________________________________________________________________________________________ 
A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one each from (2) and (3):  
1. qualitative impairment in social interaction, as manifested by at least two of the following:  
a. marked impairment in the use of multiple nonverbal behaviors such as eye-to-eye gaze, facial expression, 
body postures, and gestures to regulate social interaction  
b. failure to develop peer relationships appropriate to developmental level  
c. a lack of spontaneous seeking to share enjoyment, interests, or achievements with other people (e.g., by a lack 
of showing, bringing, or pointing out objects of interest)  
d. lack of social or emotional reciprocity  
2. qualitative impairments in communication as manifested by at least one of the following:  
a. delay in, or total lack of, the development of spoken language (not accompanied by an attempt to compensate 
through alternative modes of communication such as gesture or mime)  
b. in individuals with adequate speech, marked impairment in the ability to initiate or sustain a conversation with 
others  
c. stereotyped and repetitive use of language or idiosyncratic language  
d. lack of varied, spontaneous make-believe play or social imitative play appropriate to developmental level  
3. restricted repetitive and stereotyped patterns of behavior, interests, and activities, as manifested by at 
least one of the following:  
a. encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is abnormal 
either in intensity or focus  
b. apparently inflexible adherence to specific, nonfunctional routines or rituals  
c. stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or complex whole-
body movements)  
d. persistent preoccupation with parts of objects  
B. Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3 years: (1) social 
interaction, (2) language as used in social communication, or (3) symbolic or imaginative play.  
C. The disturbance is not better accounted for by Rett's Disorder or Childhood Disintegrative Disorder. 
______________________________________________________________________________________________ 
Developmental abnormalities are present from the first years of life in the majority of cases, but 
about one third of parents of children diagnosed with AD report that their child first seemed to 
develop normally, but then had a loss of already acquired language and social skills in the 
second or third year of life, ie an autistic regression. The regression is rarely documented except 
by parents’ reports, so it may be disputed (Rapin 1995). Recent data suggest that most of these 
children also demonstrate previous, subtle developmental delays of social and communicative 
behaviours (Rogers 2004). It is not until the function in question fails to materialize or 
materializes imperfectly that a neurodevelopmental disorder is apparent (Taylor 2003).  
A recent paper describes the high prevalence of co-morbid psychiatric disorders (specific phobia, 
obsessive compulsive disorder and ADHD) in children with autism and points out that there are 
treatments to be offered (Leyfer et al. 2006).  
  20 
The prevalence of MR is higher in autism than in the general population, especially in AD 
(Gillberg 1995; Rapin 1999). In a population-based study on autism in preschool children the 
prevalence of MR was 29.8%; in children with AD 66.7%, PDD-NOS 12% and in Asperger 
syndrome 0 (Chakrabarti & Fombonne 2005). On the other hand, population-based studies have 
shown neuropsychiatric disorders in 40% of children with MR (Einfeld & Tonge 1996; Strømme 
& Diseth 2000). Autism is much more common in individuals with an intellectual impairment: 
approximately one out of ten with MMR, and one out of three with SMR have autism (Nordin & 
Gillberg 1996, de Bildt et al. 2005) 
Aetiology 
Autism has a multitude of different aetiologies. There is strong evidence supporting a 
neurobiological basis (Volkmar & Pauls 2003). Twin and family studies suggest that most cases 
of autism arise because of a combination of genetic factors (Bailey et al. 1995; Acosta & Pearl 
2003). Macrocephaly, acceleration followed by deceleration of brain growth, increased neuronal 
packaging in the limbic system, decreased neuronal cell size particularly in the amygdale, and a 
decreased number of Purkinje cells in the cerebellum, are but some of the neuropathological 
findings that have been replicated in autism. Hughes has pointed out the finding of 
underconnectivity in the brain in autism; both MRI and fMRI studies have shown thinning of the 
corpus callosum and reduced connectivity in the frontal and temporal fusiform areas, among 
other regions (Hughes 2007). Minicolumnar pathology in the prefrontal cortex and within the 
middle temporal gyrus has been found, and it has been suggested to be the result of a different 
circuitry or spatial morphologic features in the brains of individuals with autism (Casanova et al. 
2002). Mirror neurons are cells around the sulcus centralis in the frontal and parietal lobes that 
are active not only during one’s own performance, but also when observing someone or 
something else. They are thought to be essential for empathy and considered deficient in autism, 
explaining the difficulty in understanding and predicting the behaviour or emotions of others - 
and maybe also the impaired imitation ability - often seen in autism (see review by Oberman & 
Ramachandran 2007).  
In 12-35 % of subjects with autism, an underlying medical disorder can be identified (Gillberg & 
Coleman 1996; Kielinen et al. 2004). Associated medical conditions in autism are chromosomal 
abnormalities, neurocutaneous disorders (eg tuberous sclerosis), Rett syndrome, fetal valproate 
syndrome, Möbius syndrome, central nervous system (CNS) infections and some metabolic 
disorders. MR is often part of the clinical picture.  Studies of congenital anomalies associated 
with autism have shown that there seem to be critical periods during embryogenesis (Arndt et al. 
2005; Johansson et al. 2006). It has been suggested that studies on autism aetiology and brain 
morphology should be limited to children with “essential” autism, excluding children with 
“complex” autism, ie children with microcephaly and/or abnormal physical features. This would 
allow analysis of a more uniform population and probably the group with “essential” autism is 
the more heritable subgroup (Miles et al. 2005). Ongoing research into the relationship between 
neurophysiology, neuroanatomy, neurochemistry, and genetic factors is likely to increase our 
understanding of the complex aetiology of autism. 
 
Epidemiology 
Higher awareness and changed diagnostic criteria have altered the concept that autism is rare 
(Wing 2002). The prevalence rate of AD is 0.1-0.2%, while the prevalence rate of PDD is 
considerably higher, 0.5-1%. AD is three to four times more common in males than in females. 
The sex ratio is lower among cases with SMR and higher in those with normal IQ (Gillberg 
1995).  
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Prognosis 
Follow-up studies of children with AD show variable outcome, but a majority of individuals 
have a low social functioning ability in adulthood, few live independently or are capable of 
employment and the autistic symptoms most often persist throughout life (von Knorring & 
Hägglöf 1993; Billstedt et al. 2005). Positive prognostic factors are the ability to use verbal 
communicative language in preschool years and a relatively higher IQ level (Lotter 1974; Nordin 
& Gillberg 1998), maybe at least IQ>70 (Howlin et al. 2004). Conversely, coexisting conditions, 
such as SMR and epilepsy, are considered negative prognostic factors (Nordin & Gillberg 1998). 
For the individual child diagnosed with autism, a cautious approach needs to be taken when 
discussing prognosis with the parents and the individual. The ability to function adequately in 
adult life may depend as much on interventions and support from the family, employment and 
social services as on basic intelligence (Howlin et al. 2004). 
 
 
Epilepsy and autism 
 
Epileptiform EEG abnormalities in autism 
The reported rate of epileptiform EEG abnormalities in children with autism without epilepsy 
has ranged from 6-61%, with the lowest rates if only routine EEG is used and the highest rates 
with 24-hour ambulatory EEG (Chez et al. 2006). Studies have shown that a history of autistic 
regression versus non-regression does not predict the presence of EEG epileptiform activity 
(Tuchman & Rapin 1997; Hrdlicka et al. 2004; Chez et al. 2006). There are studies showing 
normalization of EEGs with valproic acid treatment in children with autism (Chez et al. 2006), 
but no studies showing if future epilepsy can be prevented by treatment, or if there is a positive 
influence on the core symptoms and prognosis of autism. It has not been satisfactorily shown 
that treating subclinical epileptic spikes in this population improves behaviour. Possible side 
effects from AEDs - somatic, cognitive and behavioural - must be considered, as there are few 
studies on treatment and long-term effects on groups with MR with or without autism (Kerr & 
Bowley 2001). There are preliminary studies showing that some AEDs may have positive 
psychotropic effects in a subgroup of children with autism (Martino & Tuchman 2001). One 
must be aware that AD, Asperger syndrome and autistic-like conditions are behaviourally 
defined diagnoses, in contrast to the epileptic encephalopathies, eg infantile spasms, Landau 
Kleffner syndrome or the syndrome of continuous spike-and-wave during sleep (CSWS). These 
diagnoses are based on specific EEG findings together with clinical symptoms and signs and 
affect both previously healthy children and children with neurodevelopmental disorders. The 
acquired functional deficits, including cognitive and/or language regression, seen in these 
children are potentially reversible and treatable as they are presumed to be caused by 
epileptiform activity.  
 
Epilepsy in autism    
Epilepsy is more common in people with autism, with or without MR, than in the general popu-
lation (Volkmar & Nelson 1990; Gillberg 1991; Tuchman 2000; Tuchman & Rapin 2002), more 
recent studies suggesting that about one third of individuals with autism will develop epilepsy 
(Tuchman, 2000). Kielinen et al. found epilepsy in 18% of children with autism (2004). In a 
study of 100 males with Asperger syndrome presenting at a specialist unit, four had epilepsy 
(Cederlund & Gillberg 2004).  
 
According to Tuchman (2004), it is reasonable to hypothesize that many autistic symptoms 
represent underlying dysfunction in overlapping structures in the CNS, as well as dysfunction in 
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neurochemical systems, and that abnormalities in these systems may be responsible for the 
higher rates of epilepsy in this population. Tuberous sclerosis is one established cause of autism 
and epilepsy and it has been used as a model for testing theories of the brain basis of autism 
(Bolton et al. 2002). Individuals with tuberous sclerosis are at a very high risk of developing 
autism, if the onset of seizures is within the first three years of life, and when temporal tubers are 
present and associated with temporal lobe epileptiform discharges. There is a co-morbidity of 
epilepsy, autism and MR (Shah et al. 1982; Olsson et al. 1988; Volkmar & Nelson 1990; 
Steffenburg et al. 1996; Steffenburg et al. 2003). Literature reports sometimes seem to be 
contradictory due to differences in methods regarding cognitive level, aetiology, age, diagnostic 
criteria for autism and epilepsy, and duration of follow-up.  
 
Autism in epilepsy 
There are few studies on the prevalence of autism in individuals with epilepsy, but autism and 
ADHD are probably the two most common neuropsychiatric disorders in children with epilepsy 
(Besag 2002), especially if the epilepsy is drug-resistant. Davies et al. found autism in 16% of 
children with epilepsy and neurodeficits, but in none with uncomplicated epilepsy (Davies et al.  
2003). In a population-based study of children with MR and active epilepsy, autism was found in 
38% (Steffenburg et al. 1996). In a retrospective descriptive study from a rehabilitation and 
epilepsy unit only 48/573 (8%) children with epilepsy had autism, but the group with mental 
decline, 86/573 (15%), had been excluded from assessment considering autism (Boel 2004). In a 
tertiary epilepsy clinic the prevalence of autism was 32% in children, when screened with an 
autism screening questionnaire (Clarke et al. 2005). Among children with therapy resistant 
epilepsy being assessed before resective epilepsy surgery, autism was diagnosed in 19-38% of 
subjects (Taylor et al.1999; McLellan et al. 2005).  
 
Treatment and interventions for epilepsy and autism 
The assessment procedure leading to the diagnosis of autism will explain the individual’s 
sometimes seemingly illogical or odd behaviour and painful lack of social reciprocity. It will 
often be a turning point in the lives of these families. The individual and his or her family can 
find information and learn from professionals, from other parents in support groups and from the 
experiences of high functioning individuals with autism. A diagnosis makes it possible to get 
access to the services for the disabled. It will also be possible to strive for a more autism-friendly 
environment at home and at preschool, school or at work. The medical work-up will lead to the 
aetiology in some cases. The risk for future siblings or children can be discussed on the basis of 
the knowledge evolving from the genetic studies on autism. Early diagnosis is of importance, 
since interventions during pre-school years seem to result in a better adaptive behaviour level at 
school age (Eikeseth 2008).  In a review paper on the current treatment options in autism, the 
author concluded that there is not one single treatment that is declared efficacious based on well-
controlled studies, but based on current knowledge behavioural techniques and structured 
teaching based on visual cues are the most effective interventions (Francis 2005). When 
behavioural problems fail to improve by appropriate behavioural and educational approaches, 
medication can be used to facilitate management and to improve symptoms. Pharmacological 
interventions are important in epilepsy, sleep disturbance and in coexisting neuropsychiatric 
disorders, such as ADHD, depression or obsessive-compulsive disorder.  
 
Apart from AEDs, the treatment of epilepsy includes education and support to parents, teachers 
and to the person with epilepsy. It is essential to understand that treatment should be 
individualized and to take into consideration the individual’s co-morbidities and concomitant 
medications. The treatment goals are to achieve seizure control, optimal physical, behavioural 
and cognitive function using the simplest possible AED regimen. It has been shown that 
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individuals with autism can participate in prolonged EEG monitoring (Chez et al. 2006). There is 
a great challenge meeting the needs of persons with both epilepsy and autism. Since their 
communication abilities are often very limited or special, they often need to have a spokesman. 
Side effects have to be addressed carefully, as regards cognition and behaviour.  
 
Prognosis in epilepsy and autism 
In epilepsy, abnormal mental and neurological development is a negative prognostic factor, as is 
epilepsy for the outcome in autism (Gillberg & Steffenburg 1987; Kobayashi & Murata 1998).  
Given that SMR and epilepsy so often occur together, it is difficult to separate the prognostic 
effects in autism of epilepsy and SMR, respectively. There are few studies addressing the long 
term prognosis of seizure disorders in children with autism (Kobayashi & Murata 1998; 
Mouridsen et al. 1999), and no previous population-based study. In a retrospective follow-up 
study from a referral centre of 130 patients (aged 18-35 years) with autism, remission of epilepsy 
was seen in four out of 33 subjects (Hara 2007).  
 
Epilepsy surgery and autism 
Until recently there have been very few prospective follow-up studies of epilepsy surgery in 
cases with autism where the effect on the core symptoms of autism is reported, and there are no 
reports with age-matched non-operated controls. Partial recovery of social and language 
regression was reported in two children with focal epilepsy after surgical treatment (Neville et 
al.1997), and there are some more case studies (Hoon & Reiss 1992; Gillberg et al. 1996; Perez-
Jimenez et al. 2003). Szabo et al. reported neurological, neuropsychological and psychiatric 
outcome after epilepsy surgery in five children with autism (Szabo et al. 1999). McLellan et al. 
have followed the largest cohort (n=60) of children undergoing TLRs, including 23 with autism 
(McLellan et al. 2005). Discussing epilepsy surgery and the effects on autistic symptoms is a 
completely different matter from surgical treatment of autistic regression in cases with 
epileptiform activity but without clinical seizures. In most countries surgery for autistic 
regression is not performed. There are published reports though (Patil & Andrews 1998; Lewine 
et al.1999; Nass et al. 1999), but some are considered controversial and ethical concerns have 
been raised (Kanner 2000; Tharp 2004; Tuchman 2004). In cases with autism without medically 
intractable epilepsy and/or specific epileptic encephalopathies there are no data at the present 
time to support the use of surgical intervention.  
 
VNS and autism 
Studies based on the VNS Outcome Registry Data (Cyberonics, Inc., Houston, TX, USA) with 
voluntarily submitted data suggest that VNS may lead to improvements concerning alertness, 
verbal communication, memory, school/professional achievement, mood, postictal state and 
seizure clustering in individuals with autism (Park 2003; Warwick et al. 2007). There is a case 
report of a patient with Asperger syndrome and high seizure frequency successfully treated with 
VNS and followed for six months (Warwick et al. 2007). There is one prospective study 
(Rychlicki et al. 2006) and some retrospective studies on clinical case series including small 
numbers of children with autism treated with VNS for intractable epilepsy (Murphy et al. 2000; 
Parain et al. 2001; Nagarajan et al. 2002; Alexopoulos et al. 2006). These studies have not 
included neuropsychiatric assessments and there are few detailed descriptions concerning what 
exactly is implied by “a positive change” reported in some individuals with autism. 
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AIMS 
 
The purpose of this study was to gain further insight into the co-occurrence of autism and epilepsy, 
by focusing on the one hand on epilepsy in autism in a long-term perspective, and on the other 
hand on autism and other neuropsychiatric disorders in children who go through surgical 
interventions for medically intractable epilepsy. There has previously not been a population-based 
long-term follow-up study looking at epilepsy in autism, and there are few studies investigating 
the effects of epilepsy surgery on psychopathology, including autism, in children.  
 
More specifically, the aims were: 
 
-  To study the frequency, characteristics and outcome of epilepsy in a population-based series of 
children with autism growing up (study I); 
 
- To investigate differences in intellectual and adaptive level between young adults with autism 
and epilepsy, and young adults with autism without epilepsy (study I); 
 
- To assess psychopathology, including autism, in children with medically intractable epilepsy, 
undergoing epilepsy surgery, and to assess possible behavioural change after surgery (studies II 
and III); 
 
- To relate psychopathology and histopathology to seizure outcome after temporal lobe epilepsy 
surgery in children (study II); 
 
- To assess outcome concerning psychopathology, IQ and psychosocial functioning two years 
after epilepsy surgery in children (study III); 
 
-  To investigate the effect of VNS on seizures, behaviour, IQ and psychosocial functioning in 
children with autism and intractable epilepsy (study IV). 
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METHODS 
 
Study I: Epilepsy in autism – a long-term follow-up study  
 
Study group 
The study group is described in Figure 1. In 2000 to 2001, a population-based follow-up study 
was performed of 120 individuals with childhood autism born 1962-1984 (Billstedt et al. 2005). 
The recruited subjects came from three population-based studies of autism performed in the 
1980s (Gillberg 1984, Gillberg & Steffenburg 1986, Gillberg et al. 1991). In the original studies 
there were 78 children with AD and 42 with PDD-NOS (here referred to as ALC), 47% had 
SMR, 35% MMR and 18% did not have MR. At follow-up 108 individuals could be assessed. 
 
  
 
Figure 1. Subjects in study I.  
 
The assessments included a psychiatric/medical assessment and a neuropsychological evaluation 
with the Wechsler Scales and/or the Vineland Adaptive Behaviour Scale (Sparrow et al. 1984) 
and the DISCO (Wing et al. 2002). The results have been reported elsewhere (Billstedt et al. 
2005). The male to female ratio was 2.5:1. Ninety-two (85%) met DSM-IV criteria for AD, 15 
(14%) for PDD-NOS (here referred to as ALC, defined as at least four or more of the 12, but not 
full DSM-IV diagnostic criteria for AD) and one individual did no longer meet full criteria for 
AD or ALC at follow-up. SMR was present in 77/108 (71%), MMR in 25 (23%) and 6 (6%) did 
not have MR. The adaptive level was below the four year age equivalent level in 59% of the 
cases.  
 
120 from the original studies 
(36F, 84M) 
6 did not 
participate  
(2F, 4M) 
6 had died 
(3F, 3M) 
108 participated in the 
follow-up study 
(31F, 77M) 
Mean age 25.5 years 
(range 17-40 years) 
65 did not have a 
history of 
epilepsy 
(13F, 52M) 
43 had a history 
of epilepsy 
(18F, 25M) 
4 did not have a 
history of 
epilepsy 
(1F, 3M) 
 
2 had a history 
of epilepsy 
(2F) 
1 did not participate in the epilepsy 
study (1F) 
42 participated in the 
epilepsy study 
(17F, 25M) 
Mean age 26 years  
(range 18-38 years) 
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We do not have information concerning epilepsy in the six individuals who did not participate. 
Among the six who had died before follow-up we know that two had epilepsy. Both were girls 
with epilepsy onset during the first year of life and they are included when we present age at 
epilepsy onset in the cohort.  
 
Forty-three out of 108 had a history of epilepsy. The parents of one woman with active epilepsy 
declined participation in the epilepsy study. When group comparisons between the epilepsy and 
non-epilepsy groups are made in the following, this case will be included in the epilepsy group. 
Forty-two individuals with epilepsy participated in the epilepsy study.   
 
Methods  
Parents or carers were interviewed according to a systematically applied protocol. The 
individuals participated at a median age of 25 years (Q1, 21; Q3, 33, range 18 – 38 years) after 
consent from a parent or a close relative. All interviews were made by the author by telephone or 
in person at their place or at the clinic. Data extracted from the interviews concerned: seizure 
semiology, age at onset, the occurrence of status epilepticus, seizure frequency, duration and 
course of epilepsy, use of antiepileptic and psychotropic drugs, and medical services supplied. 
The medical records from child and adult medical and psychiatric assessments were not 
reviewed until after the structured interview had been analyzed, in order to avoid influence by 
the previous interpretations and investigations. Neuroimaging had been performed in 33/42 (10 
both computerized tomography (CT) and MRI; 23 only CT). Results from at least one interictal 
EEG recording were available for all cases but one.  
 
The seizure semiology and EEG findings were thoroughly discussed with an experienced child 
neurologist and seizure types were classified into four main categories (ILAE 1981): 
 
1. The partial seizure group included simple partial and complex partial seizures with or without 
secondarily generalized seizures. If there was a history of obvious focal semiology preceding a 
generalized seizure it was classified as partial, or if the seizure with or without impaired 
consciousness was associated with focal motor signs, autonomic symptoms or automatisms.  
 
2. The generalized seizure group included primarily generalized epilepsies. 
 
3. The mixed partial and generalized seizure group. 
 
4. The unclassified group included cases with insufficient descriptions of seizure semiology, 
mainly due to the difficulty to differ an epileptic seizure from behaviour in some subjects with 
SMR and autism.  
 
Studies II-IV: Autism and other neuropsychiatric disorders in 
children and adolescents with medically intractable epilepsy in the 
epilepsy surgery programme at Sahlgrenska University Hospital 
 
Study groups 
Baseline data of the three studies are shown in Table 2. 
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Table 2. Baseline data of children with intractable epilepsy  
 
 
 
 
Study II n=16 
 
Study III n=25 
 
Study IV n=8 
 
 
Type of intervention 
 
Temporal lobe resection 
 
Resective surgery or 
disconnection of HH 
 
 
VNS 
Male:female 
 
7:9 15:10 7:1 
Median age at epilepsy 
onset (years) 
 
3.2 (range 0.1-10.0) 4.0 (range 0.0-17.7) 2.8 (range 0.2-9.0)  
Median age at intervention 
(years) 
10.0 (range 3.5-19.0) 13.4 (range 4.2-19.4) 13.3 (range 5.7-18.6) 
 
   
Median epilepsy duration 
(years) 
 
5.5 (range 1.0-16.5) 6.9 (range 0.3-18.9) 9.2 (range 4.2-16.2) 
IQ≥70 
IQ 50-69 
IQ < 50 
8 
4 
4 
16 
1 
8 
1 
1 
6 
 
Neurodevelopmental 
disorders besides 
intractable epilepsy  
with or without 
psychopathology 
MR only 
MR + CP 
CP only 
8 
 
 
 
 
7 
1 
0 
 
 
10 
 
 
 
 
8 
1 
1 
8 
 
 
 
 
6 
1 
1 
 
Aetiological diagnosis 
Tuberous sclerosis 
HH 
Angelman syndrome 
Viral encephalitis 
 
 
1 
0 
0 
1 
 
 
2 
3 
0 
0 
 
 
1 
1  
1 
0 
 
Abbreviations: MR, mental retardation; CP, cerebral palsy; VNS, vagus nerve stimulation;  HH, hypothalamic hamartoma. 
 
 
Study II: Sixteen patients in a consecutive series undergoing TLRs between 1995 and 1998. The 
2-year outcome data could be assessed in 13 patients. Three were re-operated and two years had 
not passed since the last operation at the time of the study.  
 
Study III: Twenty-five patients consecutively operated with resections or disconnections 
between 2002 and May 2006. Children undergoing callosotomies were excluded, as were those 
referred to our centre from other Nordic countries. Three were re-operated during the study 
period and the follow-up assessment was made two years after the second operation. The 
surgical location was temporal in ten, frontal in eight, parietal in two, and occipital in two. In 
three subjects there were disconnections of hypothalamic hamartomas. The 2-year outcome data 
was assessed in all but one girl, who died from sudden unexpected death 22 months after 
surgery.  
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Study IV:  Eight consecutive patients with autism who started VNS treatment between 2001 and 
March 2005. One had previously been through epilepsy surgery.  In one boy the VNS treatment 
was stopped after six months due to deterioration of behaviour and increased seizure frequency. 
Seven patients were followed up after two years treatment with VNS.  
 
 
Methods 
All patients had been assessed in the epilepsy surgery programme with investigations aiming at 
finding the epileptogenic focus. As part of the pre-operative work-up there were 
neuropsychological (Studies II-IV) and neuropsychiatric (Studies III-IV) assessments, which 
were repeated at the 2-year follow-up. The overall seizure frequency was defined as the mean 
total seizure frequency per month during a period of three months before the assessment. The 2-
year seizure outcome was expressed as class 1, seizure free; class 2, not seizure free but more 
than 75% reduction of seizure frequency; class 3, 50-75% reduction of seizure frequency and 
class 4, less than 50% reduction of seizure frequency. 
 
If epilepsy surgery was not an alternative, treatment with VNS was offered (Study IV). The 
Neuro Cybernetic Prosthesis (NCP) System from Cyberonics Inc. was implanted by a 
neurosurgeon. Stimulation parameters were adjusted by a child neurologist according to standard 
practice. The stimulus intensity was increased stepwise to the highest tolerated level. In one 
patient rapid cycling (seven seconds on, 12 seconds off) was used after one year. No other 
stimulation strategies were tried. AEDs were left unchanged unless increased seizures or adverse 
effects made changes necessary. 
 
The neuropsychiatric and neuropsychological assessments 
The methods are summarized in Table 3, and described in more detail below.  
 
Assessment of psychopathology and behaviour (Studies II, III and IV) 
The retrospective assessment of psychopathology (Study II) 
The medical records from the neurological and psychological evaluations preoperatively and two 
years postoperatively were reviewed and data indicating neuropsychiatric symptoms were 
summarized. Eight children (50%) had been assessed by a child psychiatrist at some point and 
diagnosed as having a disorder according to the DSM-IV (APA 1994). For the remaining 
children the main behavioural problems were described, if they were limiting the child’s 
function in at least two situations, ie at home, at school or at visits to the child neurologist or to 
the neuropsychologist as reported in the medical records. In these eight cases we do not know 
for certain if the children with inattention and activity control problems fulfilled the actual 
criteria for ADHD according to the DSM-IV.  
 
The prospective assessment of psychopathology (Studies III and IV) 
All patients had clinical neuropsychiatric assessments by the author before and two years after 
the surgical intervention. It included an in-depth clinical  interview covering in a systematic 
fashion family and school functioning, symptoms of MR, learning disorders, communication 
disorders, PDD, attention-deficit and disruptive behaviour disorders, tic disorders, separation 
anxiety disorder, obsessive compulsive disorder and depression. Psychopathology was 
diagnosed according to DSM-IV criteria (APA 1994). Subjects diagnosed with PDD-NOS 
fulfilled at least five DSM-IV criteria for AD with or without first symptoms before the age of 
three years.  ADHD co-occurring with PDD and/or MR was diagnosed. Disruptive behaviour 
disorder not otherwise specified (DBD-NOS) was diagnosed in subjects with a behavioural 
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disturbance characterized by rage attacks, lability and disinhibition significantly interfering with 
functioning. The assessment of children with autism included further multidisciplinary work-up 
using the Diagnostic Interview for Social and Communication Disorders (DISCO) (Wing et al. 
2002), the Autism Diagnostic Observation Schedule-Generic (ADOS-G) (Lord et al. 2000) and 
in-depth discussions concerning which of the descriptive criteria of the DSM-IV that were met 
and suggestions about interventions and information to the families. 
 
 
Table 3. Neuropsychiatric and neuropsychological methods 
 
  
Study II n=16 
 
Study III n=25 
 
Study IV n=8 
 
 
Diagnostic criteria 
 
 
DSM-IV (n=8) 
 
DSM-IV 
 
DSM-IV 
Neuropsychiatric 
assessment before and 
two years after 
intervention 
Chart review 
 
 
 
 
 
Neuropsychiatric 
examination  
 
DISCO and ADOS-G 
(n=7)  
Neuropsychiatric  
examination  
 
DISCO and ADOS-G  
Questionnaires to 
parents 
 
Conners BPRS Conners BPRS 
SDQ, ASSQ 
 
ABC 
 
 
Assessment of  
behavioural change 
 
Reports from parents and 
professionals 
 
Parental perception 
 
CGI-I 
 
Assessment of 
psychosocial 
functioning 
 
 CGAS CGAS 
Assessment of 
intellectual 
ability 
Wechsler scales 
Griffiths developmental 
scales 
Wechsler scales 
Griffiths developmental 
scales 
Wechsler scales 
Griffiths developmental 
scales 
 
 
Abbreviations: DSM-IV, Diagnostic and Statistical Manual of Mental Disorders 4th edition; BPRS,  Brief  Parent Rating Scale; CGAS, 
Children’s Global Assessment Scale; SDQ, Strengths and Difficulties Questionnaire; ASSQ, Autism Spectrum Screening Questionnaire; 
DISCO, Diagnostic Interview for Social and Communication Disorders; ADOS-G, Autism Diagnostic Observation Schedule-Generic; ABC, 
Autistic Behavior Checklist; CGI-I , Clinical Global Impressions-Improvement scale 
 
 
 
Questionnaires  
- The Conners Brief Parent Rating Scale (BPRS) (Studies II and III) 
The Conners BPRS is a 10-item attention-deficit-hyperactivity questionnaire that was constructed from the Conners 
Parent Rating Scale (Conners 1994, Conners et al. 1998). The scale yields a total sum score of 0 to 30, and scores 
above 10 indicate possible ADHD.  
 
- The Strengths and Difficulties Questionnaire (SDQ) (Study III) 
The SDQ is a parent and teacher screening questionnaire of the adjustment and psychopathology of 3-16-year-olds 
(Goodman 2001). The response alternatives consist of 25 statements concerning emotional symptoms, conduct 
problems, hyperactivity/inattention, peer relationship problems and prosocial behaviour. Parents are asked to 
disagree (0), agree to some extent (1) or agree (2). The sum score of 20 items of all domains except prosocial 
behaviour generates a total difficulties score with a range of 0 to 40. A score of at least 14 on the Swedish version of 
the SDQ is considered abnormal (Malmberg et al. 2003). 
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- The Autism Spectrum Screening Questionnaire (ASSQ) (Study III) 
The ASSQ (previously known as the the Asperger syndrome and High-Functioning Autism Screening 
Questionnaire) is a 27-item parent and teacher questionnaire (Ehlers & Gillberg 1993)  that yields a total score 
ranging from 0 to 54. A score above 15 indicates a possible PDD in children 6-17 years old (Ehlers et al. 1999, 
Posserud et al. 2006). 
 
- Autistic Behaviour Checklist (ABC) (Study IV) 
The ABC is a well-established instrument measuring levels of autistic behaviour in individuals with severe 
disabilities. A total score above 67 indicates autism, and scores above 53 indicate “suspected autism” (Krug et al. 
1980).   
 
Parents were asked to return the questionnaires before and two years after surgery, but four 
chose not to do so in Study II. In Study III, parents of children with mental ages below three 
years (two boys with PDD), were not given the SDQ or the ASSQ; 19 parents returned the SDQ 
and 20 the ASSQ preoperatively. At follow-up 22 returned the SDQ and the ASSQ.  
 
Assessment of behavioural change (Studies II, III and IV) 
The 2-year behavioural outcome in Study II was based on reports from parents combined with 
the observations of the child neurologist and neuropsychologist and on changes in Conners 
BPRS scores. In Study III it was based on the parental perceptions concerning behavioural 
change two years after surgery, and was classified by the author as positive, no change or 
negative. The Clinical Global Impressions-Improvement scale (CGI-I) was used in Study IV. It 
is a clinician-rated instrument for scoring global improvement. The scale ranges from 1 = very 
much improved, 2 = much improved, 3 = minimally improved, 4 = no change, 5 = minimally 
worse, 6 = much worse to 7 = very much worse (Hollander et al. 2001). 
 
Assessment of psychosocial functioning (Studies III and IV) 
The general psychosocial functioning was assessed by the author using the Children’s Global 
Assessment Scale (CGAS). The CGAS is a single global scale with 10 verbally defined 
hierarchical levels of functioning (see Appendix). It is used to rate the general functioning of 
children under the age of 18 years and enables scoring from 1 to 100 on a hypothetical 
continuum of mental health/illness (Shaffer et al. 1983). A score above 70 indicates good 
functioning or only a mildly abnormal psychosocial situation; 70-61, some difficulty in a single 
area, but generally functioning pretty well; 60-51, variable functioning with sporadic difficulties 
in several but not all social areas; 50–41, a moderate degree of interference in functioning in 
most social areas or a severe impairment of  functioning in one area; 40-31, major impairment of  
functioning in several areas and inability to function in one of these areas; 30-21, inability to 
function in almost all areas or serious impairment in communication; 20-11 gross impairment in 
all forms of communication; a score below 10 a need for constant supervision (24-hour care).   
 
To check interrater agreement in the CGAS assessments in Study III, the first rater created 49 
case histories, describing the 25 cases pre- and postoperatively (one child died before follow-
up), which were given to an experienced child psychiatrist for scoring. The second rater was 
blind to information about diagnoses, and the case histories were randomly ordered. A total 
inter-rater agreement was found regarding children with good psychosocial functioning 
(CGAS>70). Regarding the direction of change in the CGAS at follow-up (improvement, no 
change or worsening) the two raters agreed completely in 79% of the cases. The disagreement 
concerned a range of 4-10 CGAS scores in five cases. The final classification was based on the 
assessments made by the first rater who had met and examined the children. 
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Assessment of intellectual ability (Studies II, III and IV)  
Intelligence or mental age was assessed within one year before the surgical intervention and two 
years after in all the individuals. At the neuropsychological examination the children’s level of 
functioning and mental age rather than the chronological age were taken into consideration when 
choosing the method for assessment of intelligence or development. The Swedish versions of the 
Griffiths Developmental Scales (Alin-Åkerman & Norberg 1991) or the Wechsler scales were 
used (Wechsler 1999a, Wechsler 1999b, Wechsler 2003). In subjects with severe and profound 
MR the developmental quotient (DQ) equivalent to IQ was reported. 
 
Assessment of histopathological diagnosis (Studies II and III) 
The specimens obtained at resection in Study II were re-evaluated by a neuropathologist blinded 
regarding seizure outcome and psychopathology. All histopathological abnormalities were 
recorded. In Study III the results were taken from the medical records. 
 
 
Statistical methods 
 
For comparisons of proportions across groups the Chi squared test was used and in the event of 
small numbers Fisher’s exact test was used.  Mann-Whitney test was used for non-parametric 
comparison of data from two independent groups. (Study I)  
 
The median and the quartiles Q1 and Q3 were used to describe the data. Possible changes in the 
individual’s paired data were evaluated by means of cross tables or scatter plots when suitable. 
Possible difference in proportions between groups was analyzed and the 95% confidence interval 
(CI) for the difference in proportions according to Wilson was calculated (Newcombe & Altman 
2000). A 95% CI not covering a zero difference is a sign of statistical significant difference in 
proportions, p<0.05. (Study III) 
 
 
Ethics 
 
The designs of studies I, III and IV were approved by the Ethical Committee at the Medical 
faculty at the University of Gothenburg. The retrospective Study II was considered part of a 
quality control and evaluation of the assessment procedure and outcome measures. 
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RESULTS 
Study I: Epilepsy in autism – a long-term follow-up study  
 
Overall frequency of epilepsy and epilepsy onset (n=120) 
At least 45/120 individuals (38%) with AD or ALC had epilepsy. Median age at onset was 5.5 
years (Q1, 1.25; Q3, 11.5, range 1 month to 32 years). Figure 2 shows the age at onset of epilepsy 
in the 45 individuals.   
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Figure 2. Age at onset of epilepsy in 45 individuals with autism and epilepsy.  
 
 
Twenty-seven out of 45 had SMR as children and 18 had MMR or average/near average 
cognitive ability. The median age at epilepsy onset in the 27 with SMR was 3.5 years, compared 
to 7.2 years in those without SMR, a statistically non-significant difference.   
   
 
Comparison between the epilepsy and non-epilepsy groups at follow-up 
There were 43 with epilepsy and 65 without (Table 4). In those with SMR at follow-up, 48% 
(37/77) had a history of epilepsy, in those with MMR 20% (5/25) and in those without MR 17% 
(1/6). Epilepsy was more common in females, 58% (18/31) versus 32% (25/77) in males 
(p=0.01; 95% CI 6% to 46%) and SMR was significantly more common in the epilepsy group 
than in the non-epilepsy group (p<0.01; 95% CI 8% to 40%). The adaptive behaviour level was 
lower than the four year age equivalent level significantly more often in the epilepsy group 
compared to the non-epilepsy group (p<0.05; 95% CI 3% to 39%). The adaptive behaviour level 
was below that of a one-year-old in 11/108 cases (eight females, three males). Of these, eight 
had epilepsy (19% of the epilepsy group) and three did not (5% of the non-epilepsy group) 
(p<0.01; 95% CI 1% to 27%). 
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Table 4. Gender, frequency of associated medical conditions, PDD-diagnoses, cognitive and 
adaptive levels in the epilepsy and non-epilepsy groups 
 
. 
 
Cases with epilepsy (n=43) 
 
Cases without epilepsy (n=65) 
 
Gender 
  
Male 25 (58%) 52 (80%) 
Female 18 (42%)  13 (20%) 
Male: female ratio 1.4:1 4.0:1 
 
Associated medical condition   
 
 
10 (23%) 
 
13 (20%) 
 
AD or ALC at follow-up1 
AD 
ALC 
 
 
40 (93%) 
3 (7%) 
 
52 (80%) 
12 (18%) 
Cognitive level   
SMR 37 (86%) * 40 (62%) 
MMR 5 (12%) 20 (31%) 
Not MR 1 (2%) 5 (8%) 
   
Adaptive level   
<4 year age equivalent level 
 
31 (72%) ** 33 (51%) 
 
1At follow-up one individual (without epilepsy) did not have AD or ALC. 
*p < 0.01; subjects with epilepsy versus those without 
**p < 0.05; subjects with epilepsy versus those without 
 
 
Severe MR, epilepsy and gender 
Twenty-four out of 48 individuals with SMR as children had a history of epilepsy at follow-up. 
Twelve out of the 15 females with SMR (80%) had a history of epilepsy, compared to 12/33 
males (36%), a statistically significant difference (p<0.05; 95% CI 18% to 70%). Seventy-seven 
out of 108 adults had SMR. Almost all had AD, 97% of the 37 with epilepsy and 95% of the 40 
without. Among those with epilepsy there were almost as many males as females (1.2:1), 
whereas there were almost six times more males than females in the non-epilepsy group (5.7:1). 
Epilepsy was more common in females with SMR, 17/23 (74%), than in males, 20/54 (37%) 
(p<0.05; 95% CI 15% to 59%). There were no statistically significant differences concerning the 
low adaptive behaviour level or the frequency of childhood SMR in the SMR and epilepsy and 
SMR and non-epilepsy groups.  
 
Characteristics of epilepsy in autism (n=42) 
Seizure type at onset was partial in 23, generalized in 10, mixed partial and generalized in six 
and unclassified in three. Three individuals had undergone epilepsy surgery as children, and two 
of them were seizure free with AED treatment as adults. There was no change in seizure type 
during the follow-up time or before remission in 86% of the cases. Hospitalization due to status 
epilepticus was reported in 16/42 cases (38%), and five of these had repeated episodes. Severe 
trauma secondary to epileptic seizures had occurred in 11/42 cases (26%), eg near drowning, 
fractures or head trauma. Out of the 38 with epilepsy onset before age 18 years, six (16%) had 
remission of epilepsy, defined as no seizures or medication for more than five years. Two 
additional cases were seizure free with AED treatment. 
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Active epilepsy 
At follow-up 34/42 (81%) had active epilepsy, defined as one or more epileptic seizures in the 5-
year period before the study, regardless of AED treatment. The majority, 25/34 (73%), had 
partial seizures alone or in combination with generalized seizures. Seizure frequency was more 
than one seizure per year in 24/34 (71%).  Seventeen of these had more than one seizure every 
month. Antiepileptic monotherapy was used in 19 cases and a combination of two AEDs in ten. 
Three were on three or more AEDs and two had none. Psychotropic drugs (antipsychotics, 
antidepressants and/or lithium) were used in 16/34. Intractable epilepsy, defined as more than 
one seizure every week, was seen in 11. Six of them had contact with a neurologist once or twice 
a year.  In three cases only two different types of AEDs in monotherapy had ever been tried out. 
There were no significant differences comparing the intractable and the non-intractable groups 
concerning age at epilepsy onset, gender, cognitive level or seizure types. Among those with 
active epilepsy 13/34 (38%) respondents said epilepsy had the greatest impact on the person’s 
daily life as an adult, more frequently in those with intractable epilepsy (9/11) than among those 
without (4/23), (p<0.001; 95% CI 39% to 91%). In the latter subgroup, autism and/or MR were 
most burdensome. 
 
 
 
 
Studies II-IV: Autism and other neuropsychiatric disorders in 
children and adolescents with medically intractable epilepsy in an 
epilepsy surgery programme  
 
Study II 
Data on the 16 children and adolescents treated surgically for temporal lobe epilepsy is shown in 
Table 5. Twelve out of 16 had psychopathology, most often DBD and/or autism. All the children 
with autism had MR, and three had problems with hyperactivity. The behavioural change 
postoperatively was assessed in 13 out of 16 children. The remaining three (no 6, 9, 13) were re-
operated and two years had not passed since the last operation at the time of the study, but we 
now know that one of them was seizure free two years after the re-operation (no 13), and two 
were class 3 (no 6 and 9). In 11/13 there was a positive or no behavioural change. No child 
rendered seizure free deteriorated in behaviour. One out of five children with autism became 
seizure free. The parents of the children with autism reported a positive behavioural change in 
three children (calmer, less aggressive), no change in one and there were more symptoms of 
autism in one boy. The parents of the children with attention deficits and/or hyperactivity noted 
that their children could concentrate better and/or were less hyperactive after surgery. Most 
patients had more than one histopathological diagnosis. Ten out of 12 children or adolescents 
with psychiatric problems and seven out of eight children with MR had MCD. No child with 
normal cognitive function and behaviour had MCD. 
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 Table 5. Data on 16 children and adolescents followed up two years after TLR 
______________________________________________________________________ 
 
Pat        Sex        Cognitive     Psychiatric diagnosis/       Seizure          Histopathological                         Seizure     Behavioural  
no                        status           behaviour                           frequency     diagnosis         outcome    change 
                                                                                             (per month) (class) 
 at baseline 
_________________________________________________________________________________________________________ 
  
Children with autism 
 
1* F SMR AD, hyperactivity 50 Microdysgenesis, gliosis 1 Positive 
2* F MMR AD, hyperactivity 40 Microdysgenesis, gliosis 2 Positive 
3* F MMR Asperger syndrome, 170 Postinflammatory lesions,   
   hyperactivity                         cortical  dysplasia, gliosis 4 No change 
4* F SMR AD 200 Tuberous sclerosis 3 Positive 
5* M SMR AD 100 1st op and 2nd op: focal  
    cortical dysplasia, gliosis 3 Negative 
  
Children with attention deficits with or without hyperactivity 
 
6* M MMR ADHD, DCD 750 1st op: microdysgenesis, gliosis    Reop Reop 
    2nd op: microdysgenesis, gliosis      
7* M No MR ADHD, DCD 8 Ganglioglioma 1 Positive 
8 F MMR Inattention, hyperactivity 110 Gliosis 1 Positive 
9 M No MR Inattention, hyperactivity 300 1st op: microdysgenesis, gliosis    Reop Reop 
    2nd op: microdysgenesis, gliosis               
10 F SMR Inattention, hyperactivity 235 Microdysgenesis, gliosis 2 Positive 
 
Children with other psychiatric problems 
 
11 M No MR Impulsiveness, 15 DNET, microdysgenesis 1 Positive 
 aggressiveness 
12* F No MR Depressive disorder 90 Oligodendroglioma and 1 Positive 
    microdysgenesis 
Children with no psychopathology 
 
13 M No MR - 30 1st op: DNET,  Reop Reop 
     2nd op: DNET  
14 F No MR - 15 Mesial sclerosis 2                Negative 
15 F No MR - 50 Oligoastrocytoma, gliosis 1 No change 
16 M No MR - 15 Ganglioglioma 1                No change 
_________________________________________________________________________________________________________ 
 
Abbreviations: Pat no, patient number; F, female; M, male;  AD, autistic disorder; ADHD, attention-deficit/ hyperactivity disorder; DCD, 
developmental coordination disorder; DNET, dysembryoplastic neuro-epithelial tumour; Reop, re-operated, not followed up two years after last 
operation; class 1, seizure free; class 2, not seizure free but more than 75% reduction of seizure frequency; class 3, 50-75% reduction of seizure 
frequency; class 4, less than 50% reduction of seizure frequency. 
 
* Assessed and diagnosed by a child psychiatrist 
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Study III 
Table 6 shows the main results regarding psychopathology, IQ, psychosocial functioning and 
seizure outcome. 
 
Three cases (no 11, 12, 21) had been re-operated during the follow-up period and outcome was 
assessed two years after the second operation. The histopathological diagnoses were lesions (two 
gangliogliomas, one astrocytoma and two dysembryoplastic neuroepithelial tumours (DNET)) 
(n=5), MCD (n=6), MCD in combination with gliosis (n=6), gliosis (n=2), tuberous sclerosis 
(n=2) and hypothalamic hamartomas (n=3).  
 
Psychopathology 
Psychopathology was diagnosed in 14/24 subjects at the pre-surgical assessment, and in nine of 
them there was more than one diagnosis. Seven children were diagnosed with autism. ADHD 
was diagnosed in nine, three of whom had autism. Four out of 24 children had been assessed 
psychiatrically and diagnosed with autism (no 17, 18, 24) or ADHD (no 13) before referral to the 
epilepsy surgery team. At the neuropsychiatric assessment two years after surgery, a total of 16 
children had psychopathology. In 11/16 there was more than one diagnosis. Seven children still 
had autism. In all, a diagnosis of a psychiatric disorder had been made in 17/24 children at the 
pre- or postoperative assessments and a total of 13 had autism, ADHD or both. At follow-up 
there were five new cases with emotional disorders and two new cases with ADHD-I. Among 
the children with pre-operative psychopathology, one was without a diagnosis after surgery. 
Seven of the 10 children without a pre-operative diagnosis still had no psychiatric diagnosis at 
follow-up.  
 
Questionnaires 
At the pre-operative assessment five out of 14 children with a psychiatric diagnosis reached the 
SDQ cut-off score for psychopathology, and five out of 16 children at the 2-year follow-up. The 
cut-off score for ADHD according to the Conners BPRS was reached in seven out of nine 
children with ADHD pre-operatively and in three out of eight post-operatively. The ASSQ cut-
off for autism was reached in three children pre-operatively and in two post-operatively among 
the five out of seven children with autism whose parents were given the questionnaire. 
 
Behavioural outcome  
According to the neuropsychiatric interview with parents, 12 children had a positive, four had 
none and eight had a negative behavioural change at the 2-year follow-up. A parental perception 
of a negative behavioural change was found in eight out of 17 not seizure free children and in 
none of the seizure free children (p<0.05; 95% CI 6% to 69%).   
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Table 6. Psychopathology, IQ, psychosocial functioning and seizure outcome  
 
 
DSM-IV diagnoses at 
baseline 
 
DSM-IV diagnoses at 
follow-up 
 
ID 
 
 
IQ 
at baseline 
 
IQ at 
follow-up 
 
 
CGAS 
at 
baseline 
 
CGAS  
at  
follow- 
up 
 
Seizure 
out- 
come 
(class) 
 
 
Behavioural 
change* 
 
Autistic disorder 
 
PDD-NOS, separation 
anxiety disorder 
 
 
18 
 
ModMR 
 
ModMR 
 
35 
 
61 
 
1 
 
Positive 
Autistic disorder, ODD Autistic disorder, ODD 
 
17 ModMR ModMR 
 
20 30 4 Positive 
Autistic disorder, 
DBD-NOS 
 
Autistic disorder, 
DBD-NOS 
24 PMR PMR 5 5 2 Positive 
PDD-NOS PDD-NOS 15 Near A 
 
Near A 
 
48 50 4 Positive 
         
PDD-NOS, ADHD-C, 
DBD-NOS 
 
Autistic disorder, 
ADHD-C 
1 A MMR   20 25 3 Positive 
PDD-NOS, ADHD-C, 
DBD-NOS 
 
Autistic disorder, 
ADHD-C, DBD-NOS 
16 MMR 
 
Mod MR 40 17 4 Negative 
PDD-NOS, ADHD-I, 
DBD-NOS 
PDD-NOS, DBD-NOS 23 Severe MR Severe MR 15 20 3 Positive 
         
ADHD-C, ODD  
 
0 2 A 
 
A 61 95 1 Positive 
ADHD-I, DBD-NOS ADHD-I, depressive 
disorder 
 
12 Near A 
 
Near A 67 52 4 Negative 
ADHD-I ADHD-I, DBD-NOS 13 Near A 
 
A 61 45 2 Negative 
ADHD-I, ODD 
 
ADHD-I, ODD, 
depressive disorder 
 
20 ModMR ModMR 57 47 3 Negative 
ADHD-I 
 
ADHD-I 21 ModMR Mod MR 65 65 4 No change 
ADHD-C, DBD-NOS DBD-NOS 22 ModMR ModMR 45 50 1 Positive 
         
Mixed receptive/ 
expressive language 
disorder 
Mixed receptive/ 
expressive language 
disorder 
11 Near A 
 
Near A 62 62 3 No change 
         
0 ODD, depressive 
disorder 
14 Near A 
 
A 80 60 2 Negative 
0 0 8 Near A 
 
Near A  85 85 1 Positive 
0 0 7 A A 72 91 1 Positive 
 
0 ADHD-I, separation 
anxiety disorder 
3 A Near A 82 60 2 Negative 
0 0 4 A A 95 95 1 No change 
 
0 0 5 A A 82 90 2 Positive 
 
0 0 6 A A 90 91 2 Positive 
 
0 0 10 Near A 
 
Near A 70 70 1 No change 
0 ADHD-I 9 Near A 
 
MMR 79 65 3 Negative 
0 0 19 ModMR MMR 60 51 2 Negative 
 
  
 Abbreviations: ADHD-I, attention-deficit/hyperactivity disorder – inattentive type; ADHD-C, attention-deficit/hyperactivity disorder-combined 
type; ODD, oppositional defiant disorder; DBD-NOS, disruptive behaviour disorder not otherwise specified; PDD-NOS, pervasive developmental 
disorder not otherwise specified;  A, IQ>84; Near A, IQ 70-84; MMR, IQ 50-69; ModMR, IQ 35-49; Severe MR, IQ 20-34; PMR, IQ<20; CGAS, 
Children's Global Assessment Scale; class 1, seizure free; class 2, not seizure free but more than 75% reduction of seizure frequency; class 3, 50-
75% reduction of seizure frequency; class 4, less than 50% reduction of seizure frequency.  
 *According to the reports from parents during the neuropsychiatric interview. 
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Psychosocial functioning 
Eight patients had CGAS scores above 70 at the pre-surgical assessment, and six at follow-up 
(Table 6). Subjects with autism had CGAS scores in the range 5 to 48 before surgery and those 
without autism in the range 45 to 95 (Figure 3). In 16 out of 24 there were improvements or no 
change in psychosocial functioning two years after surgery. Among the seven seizure free 
subjects no one had a worsened psychosocial functioning. The individual changes in psycho-
social functioning (CGAS) are illustrated in Figure 3.  
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Figure 3. The psychosocial functioning classified according to the CGAS before surgery 
on the x-axis and two years after surgery on the y-axis for each subject (n=24).  
 
 
 
CGAS improvement of 20 or more was seen in two individuals (no 2, 18), who became seizure 
free, one of whom had autism. CGAS deterioration of 20 or more was seen in three subjects (no 3, 
14, 16) (Table 6): one girl with autism and MMR who had an intellectual decline and no seizure 
reduction after surgery. The other two girls had normal psychosocial functioning before surgery, 
but had emotional disorders postoperatively - one with depressive disorder and ODD, and one with 
separation anxiety disorder and ADHD-I. They had their seizure frequency reduced by more than 
75%, but were not seizure free.  
An agreement was found between parents’ perception of a negative behavioural change and a 
decrease in CGAS of 9 to 23 scores. There was also an agreement between parents’ perceived “no 
change” and unchanged CGAS scores. A positive behavioural change, as perceived by the parents, 
was reflected as none or, in most subjects, a minor increase in CGAS scores. The parents of 
children with autism reported a positive behavioural change, except in one case. 
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Intellectual ability  
The individual changes in full scale IQ (FSIQ) in 23 children are illustrated in Figure 4. The 
majority, 17/23, had no change or less than eight points change in IQ. IQ remained stable in the 
majority of cases both in individuals with and without MR. Five children had a decrease of 10 or 
more IQ points. Three had a deterioration of more than 20 IQ points (no 1, 9, 16); they had 
undergone surgical procedures in the frontal lobe, had seizure outcome class 3 or 4 and two of 
them had autism. One gained 11 IQ points (no 19). 
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Figure 4. The FSIQ before surgery on the x-axis and two years after surgery on the y-axis 
for each subject (n=23). Median IQ at the presurgical assessment was 76 (Q1 47; Q3 100, 
range 14 to 128). At the 2-year follow-up median IQ was 74 (Q1 38; Q3 90, range 11 to 126).  
 
 
Baseline psychopathology was more common in the nine children with IQ<70, than in the 15 
children with average or near average intellectual ability (p<0.05; 95% CI 17% to 81%).  
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Group differences concerning seizure outcome (Studies II, III) 
Table 7 shows data from the 2-year follow-up of the 40 operated individuals in Studies II and III, 
comparing the group rendered seizure free (n=15) with the not seizure free group (n=25). There 
was a significant difference of proportion of tumours in the seizure free group (53%) compared 
to the non seizure free group (12%) (p<0.05; 95% CI 13% to 69%), while the other differences 
in proportions considering autism, IQ<70 or psychopathology were not statistically significant.  
   
 
Table 7. Group differences concerning seizure outcome (Studies II, III) 
 
  
All subjects  in studies  
II and III (n=40) 
 
Seizure free  
(n=15) 
 
Not seizure free 
(n=25) 
 
 
Female gender 
 
18 (45%) 
 
6 (40%) 
 
12 (48%) 
 
Male gender 22 (55%) 9 (60%) 13 (52%) 
    
Autism  12 (30%) 2 (13%) 10 (40%) 
    
IQ<70  17 (42%) 4 (27%) 13 (52%) 
    
Psychopathology 26 (65%) 8 (53%) 18 (72%) 
    
Tumours 11 (28%) 8 (53%)* 3 (12%) 
 
 
*p<0.05 
 
 
 
 
Study IV 
There was no change in seizure frequency at the 2-year follow-up in the seven patients with 
autism who continued the VNS treatment for intractable epilepsy. No complications were 
reported and only mild adverse effects in two subjects (intermittent hoarseness). In five the AED 
regimen was unchanged at follow-up compared to baseline. One had started on a ketogenic diet 
(no 1 in Table 8).  
 
The neuropsychiatric findings are shown in Table 8. Four patients had ADHD in addition to 
autism. Attention span and/or ability to remain seated when appropriate were positively affected 
at follow-up, but not to the extent that the diagnoses were changed. The clinical baseline autism 
diagnoses were unchanged at follow-up, as were the DISCO-algorithm diagnoses. The subjects 
in our study all had pervasive impairments, reflected in the very low CGAS scores. After two 
years of VNS treatment three subjects had a positive change (no 1, 2, 4) in the quality of social 
interactive abilities and one had a negative change (no 6) compared to baseline.  The changes 
were minor in all but one (no 2), and did not affect the overall ability to participate in daily life. 
The boy with a negative change did not interact and was mostly indifferent to everyone also at 
baseline (no 6). Before VNS three had profound, two severe, one moderate, one mild MR and 
one had average intelligence. No one improved in IQ/DQ points compared to baseline, and only 
one had a discrete improvement of mental age (no 7). One lost >20 IQ/DQ points (no 1), and 
another two lost ten or more during the two years with continuing seizures (no 4, 5). 
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Table 8. Neuropsychiatric findings and psychosocial functioning before and after two 
years of VNS  
 
 
I
D 
 
DSM-IV 
diagnoses 
at baseline 
 
ABC 
score 
before 
 
ABC 
score 
after 
VNS 
 
ADOS 
score 
before 
 
ADOS 
score 
after 
VNS 
 
CGAS 
score  
before 
 
CGAS 
score 
after 
VNS 
 
 
CGI-
I 
score 
 
Comments on behavioural change  
at follow-up 
 
 
1 
 
 
Autistic 
disorder, 
MMR 
 
 
73 
 
53 
 
22 
 
16 
 
11 
 
18 
 
3 
 
 
Social interaction with other children possible 
if guided by adult 
 
2 Autistic 
disorder, 
ADHD, 
PMR 
 
68 86 16 15 1 10 2 Less negative to others´ efforts to make  
contact 
Attention span for chosen activity up  
to 15 minutes instead of zero 
Utters some sounds with meaning if  
you know him very well 
More alert 
 
3 Autistic 
disorder, 
ADHD, 
severe MR 
 
70 - 15 - 4 - - Discontinued VNS treatment 
 
4 Atypical 
autism, 
ADHD, 
severe MR 
49 37 19 21 21 30 3 May initiate contact with others 
Can engage for a minute in something  
someone else suggests instead of not doing so 
Less easily distracted 
 
5 Autistic 
disorder, 
ModMR 
72 66 13 13 15 15 4 None 
 
6 Autistic 
disorder, 
PMR 
 
77 72 20 20 5 1 6 More passive and aloof 
More repetitive activities 
 
7 Atypical  
autism, 
ADHD, 
PMR 
 
82 78 7 4 7 7 4 Sometimes sits, but is continually restless, 
instead of having an inability to remain seated 
No change in attention span 
8 Asperger 
Syndrome 
 
8 8 15 14 50 45 4 None 
 
Abbreviations: ADHD, attention deficit hyperactivity disorder;  ABC,  Autistic Behavior Checklist; ADOS, Autism Diagnostic Observation 
Schedule; CGAS, Children's Global Assessment Scale;  CGI-I, Clinical Global Impressions-Improvement scale; PMR, profound MR (IQ<20); 
severe MR (IQ 20-34); ModMR, moderate MR (IQ 35-49); MMR, mild MR (IQ 50-70).  
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Seizure outcome and behavioural outcome in Studies II-IV 
Table 9 summarizes the 2-year outcome in all children with medically intractable epilepsy (n= 
47) in studies II-IV: seizure freedom (class 1) and behavioural outcome in children with MR 
(n=23), psychopathology (n=33) and autism (n=19), respectively. It also shows the high co-
occurrence of MR and ADHD in children with medically intractable epilepsy and autism: MR 
was present in 16 children with autism, and ADHD in nine.  
 
 
Table 9.  A summary of the 2-year outcome in Studies II-IV  
 
 
 
Study II  
n=16 
 
Study III 
 n=24 
 
Study IV  
n=7 
 
 
Seizure outcome 
-class 1 
-class 2 
-class 3 
-class 4 
 
Positive or unchanged behavioural outcome 
 
 
 
8  
3 
4 
1 
 
11 a 
 
 
7  
7 
5 
5 
 
16 
 
 
0 
0 
0 
7 
 
6 
Subjects with MR at baseline 8 9 6 
-and seizure outcome class 1 
-and seizure outcome class 1 or 2 
-positive or unchanged behavioural outcome 
2 
4 
6 a 
2 
4 
6 
0 
0 
5 
    
Subjects with psychopathology 
at baseline 
-and MR 
-and seizure outcome class 1 
-and seizure outcome class 1 or 2 
-positive or unchanged behavioural outcome 
12 
 
8 
5  
7 
9 a 
14 
 
8 
3  
5 
10 
7 
 
6 
0 
0 
6 
 
Subjects with autism at baseline 
- and MR 
-and ADHD 
-and seizure outcome class 1 
-and seizure outcome class 1 or 2 
-positive or unchanged behavioural outcome 
Autistic disorder 
PDD-NOS 
Asperger syndrome 
5 
5 
3 
1 
2 
4 
4 
0 
1 
7 
5 
3 
1 
2 
6 
3 
4 
0 
7 
6 
3 
0 
0 
6 
4 
2 
1 
    
 
a
 In study II there is missing data on behaviour at 2-year follow-up in three children due to re-operation: one child without MR or psycho-
pathology, one child with MR and psychopathology and one child with psychopathology without MR. 
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DISCUSSION 
General discussion of main findings  
 
Epilepsy in autism (Study I) 
Strengths and limitations 
The study is the first population-based cross-sectional study of adults with autism and epilepsy 
performed to date. It is also a prospective longitudinal and retrospective cohort study of children 
with autism, where the exposure is epilepsy and we study the history of epilepsy in autism. The 
rate of attrition was low, and the cohort was considered representative of autism in children as 
diagnosed at the time of the original studies (Gillberg 1984; Steffenburg & Gillberg 1986; 
Gillberg et al. 1991). The cohort does not include subjects with Asperger syndrome and only 
about one in five had IQ>70 when they were children. Therefore the results cannot be 
generalized to apply to all individuals with autism as it is defined today. Further, in cases with 
SMR and epilepsy, autism may have been underdiagnosed in the original population-based 
autism diagnostic studies, since it was shown in a later epidemiological study on children with 
MR and active epilepsy born during the same era in Gothenburg (Steffenburg et al. 1996) that 
there were previously unknown cases of AD. A prospective study specifically on epilepsy in 
autism could have given more details on the classification of epilepsy and aetiological diagnosis 
with repeat EEGs and at least one MRI.  
 
The high rate of epilepsy in autism and epilepsy characteristics  
The occurrence of epilepsy up to ages 18 to 38 years in this population-based cohort was at least 
38%. The reported rate of epilepsy in autism has varied from 7-42% and has been highest in 
studies including adolescents and young adults with SMR (Olsson et al. 1988; Volkmar & 
Nelson 1990; Tuchman et al. 1991; Mouridsen et al. 1999; Pavone et al. 2004). The atypically 
low rate of 7% was reported in children with autism without SMR or a known associated 
medical condition (Pavone et al. 2004). In a retrospective follow-up study on a clinical series of 
130 individuals 18-35 years old diagnosed with autism in childhood and without a known 
associated medical condition epilepsy was found in 25% (Hara 2007).  
 
Data from the present study indicate that the risk for epilepsy is highest in the first years of life 
and decreases from puberty and onwards. One third had epilepsy onset before age two years. 
However, four subjects had seizure onset after the age of 18 years and since the median age in 
our cohort was 25 years, our figures on epilepsy occurrence in adults with autism must be seen 
as a minimum. The bimodal distribution of epilepsy onset with a peak in both the toddler and 
adolescent periods (Volkmar & Nelson 1990) was not replicated. Rossi et al. (2000) found that 
two thirds of 18 cases with AD and MR had epilepsy onset after age 12 years, whereas the 
corresponding rate here was about one in four. In contrast with Rossi, we have not excluded 
cases of AD with congenital or acquired encephalopathy, which might explain the difference. 
Also, ours is a population-based sample which has not been the case in previous studies of 
epilepsy in autism.  
 
Generalized seizures are considered to be the most frequent seizure type in children or equally 
frequent as partial seizures in the general population (Sidenvall et al. 1996). However, the most 
common seizure type in adults is partial seizures, accounting for 60% (Forsgren 1990). It has 
previously been shown that a majority of cases with epilepsy in autism have partial seizures. In 
the study by Olsson et al. (1988), three quarters of all children with autism and epilepsy had 
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partial seizures only or in combination with other seizure types, as did three quarters of adults 
with active epilepsy in our study. The clinical symptoms of seizures and information from 
medical records were used for the classification. We had to rely on the history from parents and 
assistants, since we did not have access to video-EEG or ictal EEG recordings, except in those 
who previously had presurgical assessments. Subclassification of seizures as simple or complex 
partial could not be done. People with autism and MR can only very rarely report on 
somatosensory, special-sensory or affective seizure symptoms. Another problem is that a focal 
brain lesion may be the epileptogenic lesion triggering the seizure event, despite the lack of focal 
seizure symptoms, due to rapid generalization. Interictal EEGs were used to support the clinical 
classification, but classification of seizures was not possible in a few cases. This is not 
surprising, considering that it is hard even for close relatives or for professionals to assess what 
constitutes an epileptic seizure and what is a marked lack of awareness of the existence and 
intentions of others in some individuals with autism.  
 
Seizure frequency was more than once a year in two thirds in our study, similar to Forsgren’s 
study on the prevalence of epilepsy in MR (Forsgren et al. 1990). Among the one third of adults 
with active epilepsy who had more than one seizure every week, there was some concern that the 
individuals did not have truly medically intractable epilepsy. Some had only tried a very limited 
number of AEDs and five did not have regular contact with a neurologist, despite the fact that 
epilepsy had the greatest impact on the person’s daily life as an adult, and was considered to be 
even more burdensome than MR or autism. Patients who do not achieve adequate seizure control 
with older AEDs deserve a trial with newer AEDs. For individuals with medically intractable 
epilepsy, the treatment approach must be multiprofessional and the possibility of epilepsy 
surgery should be considered. 
 
The combination of autism, MR and epilepsy is an indicator of severe brain dysfunction and in 
23% an associated medical condition was documented in our study. MRI is the neuroimaging 
method to be preferred in an aetiological diagnosis of epilepsy, but this had only been performed 
in one fourth in our series. With the improved MRI techniques of today many of them may have 
turned out to have MCD.   
Childhood onset epilepsy often remits, but less often in cases with more than one type of seizure, 
abnormal mental and neurological development or with a detectable cause (Brorson & Wranne 
1987). An early response to AED is the single best predictor of remission (Sillanpää et al. 1998). 
The rate of epilepsy remission in a population-based cohort of children with autism growing up 
has not previously been described. In our study it was only 16 %, and probably reflects the 
underlying brain dysfunction.  
SMR and female gender as risk factors for epilepsy in autism 
Epilepsy is more common in SMR than in MMR or no MR (Forsgren et al. 1990; Tuchman et al. 
1991; Steffenburg et al. 1995). Many studies on the epidemiology of epilepsy and MR have 
previously lacked data about autism, but now the concept of autism spectrum disorders has 
developed and there is a growing awareness and knowledge about autism among specialists and 
the general public alike (Wing & Potter 2002). Almost half the group with SMR and autism in 
our sample had epilepsy by early adult life, whereas epilepsy in MMR occurred in 20%. The 
incidence of epilepsy is slightly higher in males than in females (Christensen et al. 2005). 
Epilepsy was significantly more common in females with autism than in males in our study, 
which has been observed previously (Volkmar & Nelson 1990; Tuchman et al. 1991; Elia et al. 
1995). Females are less likely to have autism without more severe brain dysfunction (Volkmar & 
Nelson 1990; Elia et al. 1995). Women with autism and SMR significantly more often had 
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epilepsy compared to men with the same diagnoses in our study. A recent meta-analysis 
concluded that the risk for epilepsy in autism is a function of severity of intellectual disability 
and suggested that autism associated with epilepsy is a subgroup of autism distinguished by its 
male to female ratio (Amiet et al. 2008).  
 
Epilepsy as a negative prognostic factor for outcome in autism 
Epilepsy is considered to be a negative prognostic factor for the outcome of autism (Kobayashi 
& Murata 1998; Nordin & Gillberg 1998), as was shown in our study. Billstedt et al. (2005) 
described the outcome of the whole study population (n=108) as very poor in 57% (no ability to 
lead any kind of independent existence and no clear verbal or non-verbal communication), and 
poor in another 21% (no independent social progress but some clear verbal or non-verbal 
communication). The group of adults with autism and epilepsy in our study had significantly 
more often SMR and a very low adaptive level compared to adults with autism and no epilepsy. 
Given that SMR is often a co-morbid feature it is difficult to separate the prognostic effects on 
autism of epilepsy and SMR respectively. Aicardi has pointed out that the disturbance resulting 
from epilepsy tends to multiply the disability rather than simply add to other difficulties in 
individuals with neurodevelopmental disorders (Aicardi 1998).  
 
 
Autism in medically intractable epilepsy (Studies II-IV) 
Strengths and limitations 
Studies II-IV are case series reports with small numbers, but a strength is that they are 
descriptive studies of consecutive cases. The subjects in study II and III represent a subgroup of 
children with medically intractable epilepsy referred to and operated at an epilepsy surgery 
centre with a population-based referral system. It differs from a prospective controlled study 
where the aim is to test a hypothesis and the groups consist of samples from populations. Studies 
III and IV are prospective evaluation studies performed on all children eligible for a 2-year 
follow-up. The value of the studies is the multivariate follow-up of outcomes; each child was 
compared to itself and diagnoses were based on in-depth clinical neuropsychiatric examinations 
and neuropsychological assessments. One aim of study III was to evaluate the complexity of 
these children’s problems. Such an evaluation is important if one wants to shed light on the fact 
that the outcome in this group is very heterogeneous and involves various variables. Conclusive 
comments concerning epilepsy surgery being the cause of observed outcomes cannot be made 
without an appropriate comparison group. This is a dilemma in outcome studies concerning 
paediatric epilepsy surgery; the heterogeneity in paediatric epilepsy surgery candidates is much 
greater than in adults and recurrent seizures may represent a considerable risk for intellectual 
decline in children, while intellectual functioning seem to be less vulnerable in adults (Bjørnæs 
et al. 2001). Only one epilepsy surgery study using a comparison group in the form of accepted 
candidates for surgery (in adults) has been published (Wiebe et al. 2001). When assessing the 
seizure outcome after surgery in our studies, only changes in seizure frequency has been 
reported, and not changes in seizure severity. Even if seizure frequency is reduced or unaltered, 
the seizure types may change for the better or the worse. Study II is a retrospective study on 
psychopathology conducted when neuropsychiatric evaluations pre- and postoperatively were 
not part of the epilepsy surgery programme in Sweden. It can be looked upon as a pilot study 
leading on to the prospective studies III and IV. We have used up-to-date measures and criteria 
for case definitions. We chose to define PDD-NOS very stringently in order not to include 
uncertain cases. Although the DSM-IV criteria for neuropsychiatric disorders are not validated 
for use in children with intractable epilepsy, the ILAE commission on psychobiology of epilepsy 
recommends that co-morbid psychopathology should be classified using conventional criteria 
(Krishnamoorthy et al. 2007).  
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The high frequency of neuropsychiatric disorders in epilepsy surgery candidates  
The largest published follow-up study addressing effects on psychopathology in children 
undergoing epilepsy surgery is a case-note review of performed neuropsychiatric assessments 
before and after TLRs (McLellan et al. 2005). A psychiatric disorder at some point was found in 
that study in 50/60 children (83%) and our corresponding numbers were 12/16 (75%) in children 
undergoing TLRs and 17/24 (71%) in children undergoing different surgical procedures for 
epilepsy. Just as in McLellan’s study the most common neuropsychiatric disorders were autism 
and DBD and there was a high rate of psychiatric co-morbidity. The neurodevelopmental 
disorders described in the first part of the DSM-IV start at an early age and often occur together. 
This is also true in the general population of children (Kadesjö & Gillberg 2001), and not just in 
epilepsy surgery candidates. Psychiatric disorders were more common in children with IQ<70. 
Epilepsy is more frequent and often more difficult to treat in children with MR, and children 
with MR are at higher risk of psychopathology (Strømme & Diseth 2000). 
 
The proportion of affected children was not smaller two years after surgery, which is in line with 
McLellan’s study. In study III, the neuropsychiatric disorders completely resolved post-
operatively in one child, and in three children without psychopathology pre-operatively, 
neuropsychiatric disorders evolved post-operatively.  
 
ADHD tends often to be of the combined type in children without epilepsy, but in children with 
epilepsy the inattentive type seems to be at least as common as the combined type (Dunn et al. 
2003). In Study III, ADHD-I was more common than ADHD-C. It has been suggested that 
children with epilepsy and ADHD-C are more likely to have truly independent co-morbid 
conditions and those with ADHD-I and epilepsy have a co-morbidity in which the inattention 
and epilepsy are both related to a common central nervous system disturbance (Noeker & 
Haverkamp 2003). However, in our small series two boys with ADHD-C no longer had ADHD 
at follow-up. They were both seizure free after surgery. 
 
In McLellan’s study (2005) the majority of children with emotional disorders developed these 
postoperatively, consistent with the findings in our study. Depressive disorder was diagnosed in 
three not seizure free teenagers at follow up in Study III. Symptoms of depression in children 
with epilepsy are often under-recognized and more common than in children without epilepsy 
(Dunn et al. 1999).   
 
In several outcome studies, data on behaviour is drawn from questionnaires. The questionnaires 
were not used to assess behavioural outcome in studies III and IV. We would not have 
identified all the children with psychopathology if we had only used the parental questionnaires 
SDQ, Conners BPRS and the ASSQ. Another parental questionnaire, the Childhood Behavior 
Checklist (CBCL) (Achenbach 1991), has been used to document behavioural outcome after 
epilepsy surgery (Smith et al. 2004; Elliott et al. 2008; Gleissner at al. 2008).  Efforts have also 
been made to create more epilepsy-specific questionnaires not only in adults, but also in 
children, including the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE) (Sabaz 
et al. 2000). There is not yet a Swedish translation of this questionnaire.  
 
There have been three papers on behavioural outcome after epilepsy surgery using the CBCL 
and control groups for studying behavioural outcome. Compared to the control groups, Lendt et 
al. showed an improvement of behavioural problems in the operated group three months after 
surgery (2000), while Smith and Elliott et al. showed no changes in psychosocial functioning 
within the first year, but significant effects on the social competence and social problem subscale 
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scores after two years (2004 and 2008). The comparison groups in these studies consisted of 
children with drug-resistant epilepsy who could not be accepted for epilepsy surgery and the 
children were not neuropsychiatrically assessed. Based on our results, we would advocate 
neuropsychiatric assessments comparing and describing psychopathology before and after 
surgery rather than relying on group analyses of questionnaires, and to treat data as dependent 
before and after intervention. 
 
In Study III psychiatric disorders were more common in children not rendered seizure free by 
surgery, and the parents of children who did not become seizure free perceived a negative 
behavioural change significantly more often than the parents of seizure free children. A small 
positive behavioural change may be considered very positive in a severely impaired child, even 
if it does not change the global functioning level or cognitive abilities, and a negative 
behavioural change may affect the psychosocial functioning level very much in a child with 
average or near average intellectual ability. This should be taken into consideration at the pre-
operative counselling.  
 
The low rate of previously neuropsychiatrically assessed children with intractable epilepsy 
despite behavioural difficulties (Study III) 
Only four out of the 25 individuals in this group had been assessed psychiatrically before referral 
to our centre. It is known that behavioural and emotional problems often go undiagnosed in 
individuals with epilepsy, even if these problems may be the most burdensome (Steffenburg et 
al. 1996; Devinsky 2003; Kanner 2003; Ott et al. 2003). To recognize and address the beha-
vioural issues is a crucial first step to treatment irrespective of seizure frequency. Even if the 
cause is multifactorial (Austin & Caplan 2007), the interventions are built on parental awareness 
of the child’s impairment, and may include behavioural modification, rehabilitation and in some 
cases medication. 
 
Autism and epilepsy surgery (Study II, III) 
Almost one third of the epilepsy surgery candidates had autism, a frequency within the range of 
two previous studies (Taylor et al. 1999; McLellan et al. 2005). We found a high co-morbidity of 
MR and ADHD in autism and medically intractable epilepsy. In McLellan’s study MR was 
significantly associated with autism; only 22% of cases with autism did not have MR compared 
with 73% of children without autism, and among the 16 children with ADHD, nine had also 
autism. It has been shown that autism is common in individuals with MR and epilepsy 
(Steffenburg et al. 1996), and more common in individuals with SMR than in MMR (de Bildt et 
al. 2005). 
 
The lack of effect of surgical resections for epilepsy concerning the core symptoms of autism is 
in line with the studies by Szabo et al. (1999) and McLellan et al. (2005). In McLellan´s study 
21/23 with autism still had autism at follow-up. They were described as improved (n=11), no 
change (n=7) and deteriorated (n=3); 43% of children with autism were seizure free after 
surgery, compared to 70% of children without autism, a statistically non-significant difference. 
In the prospective study by Szabo et al. on five children with autism, four had TLRs and one had 
a temporo-parieto-occipital resection. Two years after surgery all children still had autism and 
developmental delay, but one child showed substantial improvement on all measures, despite 
persistent seizures. Four children were seizure free: two demonstrated mild improvement, one no 
improvement and one decline. The proportion of affected children was not smaller two years 
after surgery in our studies. Even if there was no change in PDD-diagnosis in most of the 12 
individuals with autism in Studies II-III and only two became seizure free and another two had 
>75% reduction of seizure frequency, parents perceived improvements in behaviour after 
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surgery in ten children. The fact that the parents of six out of seven children with autism in study 
III reported positive behavioural effects at follow-up, but five out of six still had severe 
impairments in psychosocial functioning is an illustration of the pervasiveness of autism.  
 
The stability of intellectual ability after surgery in children with or without MR (study III) 
IQ remained stable at a group level as shown by others (Adams et al. 1990; Szabo et al. 1998). 
This was true also for a majority of individual cases with or without MR. Epilepsy and AEDs 
can cause a state-dependant learning disability that must be distinguished from MR, because it is 
potentially reversible (Besag 2001). It is only in exceptional cases that the cognitive impairment 
is an effect of epileptiform EEG discharges; on the other hand these discharges seem to have an 
additional mild negative effect concerning the mental processes alertness and mental speed 
(Aldenkamp & Arends 2004).  
 
Histopathology, psychopathology and seizure outcome 
The histopathological findings were indicative of developmental anomalies of the brain in 10/12 
subjects with medically intractable epilepsy and pre-operative behavioural problems and/or 
psychiatric diagnoses in Study II. The fact that eight had MR in addition to the seizure disorder 
may indicate a more diffuse pathological process. In all, eight out of 16 (50%) became seizure 
free in Study II. Post-operative seizure outcome is related to histopathological diagnosis. In the 
Cleveland Clinic paediatric series (n=136) seizure free outcome was present in 82% after 
surgery due to tumour, versus 52% in MCD (Wyllie et al. 1998). In a review by Sisodiya (2000), 
approximately 40% of cases with a histopathological diagnosis of MCD were rendered seizure 
free after surgery. Using volumetric MRI data, extralesional volumetric abnormality of gray and 
subcortical matter has been demonstrated in patients with MCD and epilepsy, indicating the 
existence of extensive structural disorganization outside visually identified focal lesions 
(Sisodiya et al. 1995). MCD are being recognized as one of the causes of epilepsy, MR, autism 
and other neurodevelopmental disorders (Taylor et al. 1971; Purpura et al. 1982; Humphreys et 
al. 1990; Piven et al. 1990; Meencke & Veith 1992; Kuzniecky et al. 1994; Casanova et al. 2002; 
Palmini et al. 2004). Even with high-resolution MRI, MCD may remain undetected and may 
only be histologically found after epilepsy surgery (Raymond et al. 1995). The pathogenetic 
relevance of microdysgenesis in epilepsy has been a matter of controversy for many years. 
However, Nordborg et al. (1999) reported that patients with intractable seizures with the 
histopathological finding of microdysgenesis closely resemble those with major malformations 
in several clinical aspects. They had significantly more often MR and had a significantly lower 
age at seizure onset than the patients without parenchymal malformations.  
 
In the study by McLellan et al. (2005), MCD were reported in 15/60 cases, much less often than 
in our study. They did not find a correlation between neuropsychiatric status and seizure 
outcome except when comparing children with the same histopathological finding of 
hippocampal sclerosis (33 cases: 12 with autism and 21 without) where the seizure outcome was 
significantly better in cases without autism than in those with autism. Except for the difference 
in proportion of tumours in the seizure free group compared to the non seizure free group in 
Studies II and III, the other differences in proportions considering autism, IQ<70 or 
psychopathology were not statistically significant.   
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Psychopathology and psychosocial dysfunction (Study III-IV) 
These are the first studies using CGAS to examine outcome considering psychosocial 
functioning after epilepsy surgery and VNS treatment respectively. CGAS is not a measure of 
epilepsy-specific impact; it reflects impairments and disabilities in social interaction, 
communication and behaviour. The global assessment scale revealed psychosocial dysfunction 
in the majority of cases in our studies. Cases with autism had the lowest scores before surgery 
and the scores remained quite stable in most cases. The CGAS could be used to illustrate the 
problem panorama in children with severe epilepsy and psychopathology. The scale has an 
advantage compared with the CGI-I or parents’ perception of behavioural change, in that the 
total situation of the patient is evaluated and not just particular symptoms. The Vineland 
Adaptive Behaviour Scales (Sparrow et al. 1984) could also be used in future studies on outcome 
of epilepsy surgery for a general assessment of adaptive behaviour, concerning communication 
skills, socialisation, daily living skills and motor skills. The scales have been used in two 
population-based follow-up studies on autism – one in children with previous infantile spasms 
(Saemundsen et al. 2007), and the other one in the cohort used in Study I (Billstedt et al. 2005). 
 
Autism and VNS  
Since there have been reports on positive effects on quality of life and behaviour with VNS, both 
in patients with improved seizure situation and in those without (Lundgren et al. 1998; Valencia 
et al. 2001; Hallböök et al. 2005), it was important to study possible VNS effects on 
psychopathology in our patients with autism and to report the results, even if no-one achieved 
seizure control. Our disappointing results concerning seizure control may reflect the severe 
underlying encephalopathy in our subjects, the more long-standing severe epilepsy and/or the 
difficulty in our group to tolerate higher stimulation parameters (Aldenkamp et al. 2002; Majoie 
et al. 2005; Alexopoulos et al. 2006; Rychlicki et al. 2006). The use of a combination of many 
AEDs is often unavoidable in children with intractable epilepsy not eligible for epilepsy surgery, 
with a high risk for cognitive and behavioural side effects. The side effects of VNS are 
considered to be minor, and there are no known negative interactions with AEDs. VNS may 
facilitate a reduction in AED treatment, but there are studies reporting a failure to do so (Murphy 
et al. 2003; Alexopoulos et al. 2006). Our low rate of complications and type of side effects 
reported are in line with previous reports (Labar 2000).  
 
Studies based on the VNS Outcome Registry Data (Cyberonics, Inc., Houston, TX, USA) 
suggest that chronic VNS may lead to improvements in autism (Park 2003; Warwick et al. 
2007). The registry has weaknesses - biases in selection, assessment and voluntary reporting of 
subjects. The patients analyzed do not necessarily represent all patients in the registry with 
autism, and the criteria used for the reported diagnosis are not known. In a few mostly 
retrospective follow-up series with VNS treated children, one to nine children diagnosed with 
autism have been included (Murphy et al. 2000; Parain et al. 2001; Nagarajan et al. 2002; 
Alexopoulos et al. 2006; Rychlicki et al. 2006; Warwick et al. 2007). It is hard to draw 
conclusions about the behavioural effects on children with autism from these reports, since it is 
not known if and how all children in the series have been neuropsychiatrically assessed. In the 
paper by Murphy et al. (2000) disruptive behaviours are described to have disappeared, but this 
does not necessarily mean that the overall situation, concerning ability to participate in social 
interaction, need for supervision or core communication symptoms of autism have changed. 
When core symptoms of autism do change, eg in a child with autism who earlier did not make 
social approaches actively but now does so, it is of course positive for that child and gives 
him/her opportunities to develop. However, this might lead to an increased need for constant 
supervision, as well as to major changes in the approach needed at school and/or at home.  
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The hypothesis from our study is that in children with autism without effects on seizure control, 
the behavioural effects concerning the core symptoms of autism are minor, if any. Increased 
alertness has been reported in some children treated with VNS (Lundgren et al. 1998; Helmers et 
al. 2001; Hallböök et al. 2005; Majoie et al. 2005). Since alertness is the prerequisite for 
sustained, focused and divided attention this might be the reason for the improvement 
concerning attention span and/or ability to remain seated when appropriate in the three children 
with ADHD and autism in our study. 
 
There are few studies on cognitive effects of VNS in children. No patient in our series improved 
in IQ/DQ scores over time. The developmental arrest or mental decline probably reflects an 
ongoing adverse influence caused by seizures on cognitive development. VNS was considered 
not to influence cognitive level or quality of life measurements unfavourably after two years of 
treatment in one prospective study of 19 children (Majoie et al. 2005). In another prospective 
study on 16 children there were no differences in cognitive functioning before and after nine 
months’ treatment with VNS for most children; 2/15 improved and one deteriorated. In the four 
children with SMR there were no improvements (Hallböök et al. 2005). 
 
 
 
Practical implications of findings 
 
The findings that almost one third of adults with childhood autism and MR had active epilepsy 
and that the majority of children with autism, MR and epilepsy will become adults with the same 
diagnoses and with a low adaptive level in daily life, should be heeded by health administrators 
when planning resources. The study raises the question whether individuals with autism, MR 
and epilepsy are optimally taken care of by the medical system. Adults with autism and MR are 
severely impaired, but epilepsy with frequent seizures will aggravate their situation further. 
Also, onset of epilepsy may occur in adulthood. A big issue is the need for education concerning 
epilepsy in the “autism-friendly” environment and for education about the needs of a person with 
autism in the “epilepsy-friendly” environment. It is a delicate balance to investigate 
comprehensively enough for the best possible care and to respect the aloofness of some 
individuals with autism and not put these individuals into stressful situations. On the other hand, 
such respect must never be an excuse for not investigating, diagnosing and treating epilepsy in 
people with autism and MR.  
 
The high frequency of neuropsychiatric disorders in children with drug-resistant epilepsy makes 
comprehensive and structured diagnostic practice concerning psychopathology in this group 
important and necessary. Even in children with intractable epilepsy there are potentially treatable 
co-morbid disorders and diagnosis is the first step to interventions and support. Early diagnosis 
and interventions for autism seem to affect the future adaptive level in a positive way, and there 
is no reason to think that this does not apply to preschool children with the combination of 
epilepsy and autism. For many parents or assistants, the behavioural and cognitive impairments 
become linked with the epilepsy. They might therefore set hopes that a surgical intervention for 
epilepsy per se will improve the whole situation. It should be part of the neuropsychiatric pre-
operative assessment to discuss realistic goals, and it cannot yet be stated that there is a clear 
relationship between seizure outcome and behavioural effects. A goal of achieving better seizure 
control after epilepsy surgery is a realistic one, whereas a goal of improving the psychosocial 
situation in children with co-morbid psychopathology is unrealistic unless effective interventions 
are offered. Trying to rate the overall psychosocial functioning is mandatory if one wants to 
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better understand the complexity of the impairments and disabilities in children with autism and 
epilepsy. Symptoms change more quickly than functioning. 
 
The studies further suggest that we need more precise background data concerning cognitive 
level, psychopathology and psychosocial functioning to be able to discuss outcome of epilepsy 
surgery in future studies. Questionnaires, observational schedules for autism and validated 
structured interviews are not adapted to children with on-going severe epilepsy or gradual mental 
decline. Such instruments are never sufficient as the only source of data on which to base a 
diagnosis, but together they can add valuable information that is comparable from one clinic to 
another. However, the clinical neuropsychiatric evaluation, history taking and use of agreed 
diagnostic criteria, in combination with the neuropsychological assessment, are still the most 
important tools that can be used assessing psychopathology. Studies need to be descriptive and 
every child needs to be compared to itself.  
 
Multicenter studies are necessary to accumulate a sufficiently large number of cases to study 
effects of epilepsy surgery on children with autism. The results to date suggest that families 
should be made aware of the fact that behavioural symptoms in children with focal epileptogenic  
lesions and autism may or may not improve after epilepsy surgery. This makes it important to 
diagnose autism before surgery; otherwise parents’ expectations may be too high. 
 
Finally the study hopefully leads to increased awareness of individuals with both epilepsy and 
autism, so that optimal support and interventions can be provided and planned for through the 
collaboration between psychiatry and neurology.  
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CONCLUSIONS 
 
In a community based sample of individuals with autism followed from childhood through to 
adult age it was shown that more than one third had epilepsy and that the remission rate of 
epilepsy was low. Epilepsy onset was most often in the first years of life, but also occurred in 
adults. Seizure frequency had a great impact on the individuals’ lives. Partial seizures were the 
dominating seizure type. SMR and autism were significantly associated with epilepsy, especially 
in females. Epilepsy was a negative prognostic factor concerning cognitive and adaptive 
outcome. In two consecutive case series of children with drug-resistant epilepsy undergoing 
epilepsy surgery neuropsychiatric disorders were common at baseline and two years after 
intervention. Only few children had been assessed concerning the behavioural difficulties before 
referral to the epilepsy surgery team. A neuropsychiatric disorder contributed on a large scale to 
the psychosocial dysfunction in children with medically intractable epilepsy. The parents of 
children who did not become seizure free perceived a negative behavioural change significantly 
more often than the parents of seizure free children. The IQ level before surgery predicted the IQ 
level after surgery in most cases. Almost one third had autism, in combination with MR in most 
cases, and with ADHD in half of the cases. A diagnosis of autism remained after surgery. In a 
consecutive case series of children with severe epilepsy and autism treated with VNS, changes 
concerning behaviour, intellectual abilities and psychosocial functioning were minor when there 
was no reduction of seizure frequency. Further studies are needed to assess outcome regarding 
psychopathology and psychosocial functioning after epilepsy surgery and VNS treatment. 
 
  55 
SAMMANFATTNING PÅ SVENSKA 
 
De flesta barn med epilepsi blir anfallsfria med läkemedelsbehandling och epilepsin är 
övergående. Epilepsi hos barn med utvecklingsrelaterad funktionsnedsättning, t ex autism, är 
mer svårbehandlad. Den här avhandlingen handlar dels om epilepsi hos individer med autism, 
dels om neuropsykiatriska funktionsnedsättningar hos barn med så svårbehandlad epilepsi att 
epilepsikirurgi är ett alternativ. 
 
Målsättningen med studien var att öka kunskapen kring samsjukligheten mellan autism och 
epilepsi. I en långtidsuppföljande delstudie på vuxna med autism var syftet att beskriva 
förekomsten av epilepsi och hur ofta epilepsin är övergående samt att jämföra hur individer med 
respektive utan epilepsi mår och har utvecklats. I de tre övriga delstudierna har olika aspekter på 
neuropsykiatriska funktionsnedsättningar, framför allt autism, studerats hos barn med 
svårbehandlad epilepsi som genomgår epilepsikirurgi eller får behandling med 
vagusnervstimulering (VNS).   
 
I en populationsbaserad uppföljningsstudie av 120 individer diagnostiserade med autism i 
barndomen, kunde 108 bedömas på nytt i 17-40-årsåldern. Som vuxna hade majoriteten 
utvecklingsstörning och alla utom en hade fortfarande autism. Av de 43 som hade eller hade haft 
epilepsi, intervjuades närstående till 42 och en analys gjordes av journaler från barn- och 
vuxensjukvården (Studie I). I delstudierna av autism och andra neuropsykiatriska funktions-
nedsättningar hos barn med svårbehandlad epilepsi, studerades två konsekutiva serier av barn 
som genomgick epilepsikirurgi på Sahlgrenska Universitetssjukhuset i Göteborg: en retrospektiv 
journalstudie av 16 barn som genomgick temporallobsresektion mellan 1995 och 1998 (Studie 
II) och en prospektiv studie på 25 barn som genomgick epilepsikirurgi mellan 2002 och maj 
2006 (Studie III). I det fjärde delarbetet redovisas en prospektiv studie på 8 barn med autism 
vars epilepsi inte var operabel och som fick behandling med VNS. I de prospektiva studierna 
gjordes en klinisk neuropsykiatrisk bedömning och diagnostisering enligt vedertagna 
diagnoskriterier, en bedömning av psykosocial funktionsnivå och en neuropsykologisk 
bedömning av begåvningsnivå före och två år efter interventionen (Studie III och IV).  
 
Vuxna med autism och utvecklingsstörning hade en uttalad funktionsnedsättning och ca 1/3 hade 
epilepsi. Av dessa 43 hade 1/3 haft epilepsidebut före 2 års ålder, men insjuknande förekom 
även upp i vuxen ålder. Epilepsin var övergående under uppväxten hos sex individer. Partiella 
anfall med eller utan sekundär generalisering var den dominerande anfallstypen, och 1/3 med 
aktiv epilepsi hade fler än ett anfall varje vecka. Riskfaktorer för epilepsi var kvinnligt kön och 
IQ<50. När vuxna med epilepsi jämfördes med dem utan epilepsi var både begåvningsnivån och 
funktionsnivån lägre i gruppen med epilepsi.  
 
I den retrospektiva studien av temporallobsopererade barn hade 12 av 16 barn neuropsykiatrisk 
funktionsnedsättning. Fem hade autism före och efter operationen, varav en blev anfallsfri, och i 
tre fall noterades en positiv beteendeförändring vid uppföljningen. Missbildning av hjärnbarken 
var associerad med sämre utfall avseende anfallsfrihet och var vanligare hos barnen med 
psykopatologi. I den prospektiva studien av opererade barn hade 17 av 24 uppföljda barn 
psykopatologi före eller efter operationen eller både och. Fyra av barnen hade bedömts av läkare 
avseende beteendesymtomen före den epilepsikirurgiska utredningen. Begåvningsnivån var 
stabil efter operationen i de flesta fall, även hos barn med utvecklingsstörning. 13 barn hade 
autism, ADHD eller bägge. Sju hade autism före och efter operationen, varav en blev anfallsfri. I 
sex fall upplevde föräldrarna en positiv beteendeförändring, men barnens låga psykosociala 
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funktionsnivå var i fem fall av dessa väsentligen stabil. Barnen med autism som behandlades 
med VNS fick ingen anfallslindring, och behandlingen fick avslutas hos en pga försämrat 
beteende. Hos de sju som kunde följas upp efter två års behandling noterades ingen positiv 
förändring avseende intellektuell utveckling eller psykosocial funktionsnivå och oförändrad 
autism-diagnos, men positiv förändring av vissa beteendesymtom hos tre och negativ förändring 
hos en.  
 
Slutsats 
 
En tredjedel av individerna med autism i barndomen och utvecklingsstörning fick under 
uppväxten epilepsi. IQ<50 och kvinnligt kön var riskfaktorer. Epilepsin var varaktig i 
majoriteten av fallen, svårbehandlad hos 1/3 och en negativ prognosfaktor avseende IQ och 
funktionsnivå. Närstående upplevde att svårbehandlad epilepsi var mer betungande än både 
autism och utvecklingsstörning hos dessa individer. Barn med svårbehandlad epilepsi som 
genomgick epilepsikirurgi var en heterogen grupp, där mer än två tredjedelar hade 
neuropsykiatriska diagnoser – oftast autism och/eller ADHD – som bidrog till en låg psykosocial 
funktionsnivå. Beteendeproblemen hade i de flesta fall inte diagnostiserats tidigare vilket kan 
tala för ett otillräckligt tillsett behov hos barn med svårbehandlad epilepsi. Förekomsten av 
psykopatologi var högre hos barn som hade en samtidig utvecklingsstörning och hos barn som 
inte blev anfallsfria. Autism, liksom utvecklingsstörning, fanns kvar efter epilepsikirurgi, men 
anfallsfrihet tycktes kunna påverka den psykosociala funktionsnivån positivt i vissa fall vilket 
behöver studeras ytterligare. Behandling med VNS som inte resulterar i anfallsreduktion tycktes 
inte påverka kognitiv eller psykosocial funktionsnivå hos barn med svårbemästrad epilepsi och 
autism, men fler prospektiva studier behövs. Att aktivt sträva efter en så optimal anfallssituation 
som möjligt är minst lika angeläget hos dessa individer som hos individer utan autism. 
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APPENDIX 
 
The Children’s Global Assessment Scale (CGAS) (Shaffer et al. 1983) 
 
100-91 
Superior functioning in all areas (at home, at school and with peers), involved in a range or activities and has many 
interests (eg, has hobbies or participates in extracurricular activities or belongs to an organized group such as 
Scouts, etc). Likable, confident, "everyday" worries never get out of hand. Doing well in school, no symptoms. 
  
90-81   
Good functioning in all areas. Secure in family, school and with peers. There may be transient difficulties and 
"everyday" worries that occasionally get out of hand (eg mild anxiety associated with an important exam, 
occasional "blow ups" with siblings, parents or peers). 
  
80-71  
No more than slight impairment in functioning at home, at school, or with peers. Some disturbance of behaviour or 
emotional distress may be present in response to life stresses (eg, parental separations, deaths, births of a sib) but 
these are brief and interference with functioning is transient. Such children are only minimally disturbing to others 
and are not considered deviant by those who know them. 
  
70-61   
Some difficulty in a single area, but generally functioning pretty well, (eg, sporadic or isolated antisocial acts, such 
as occasionally playing hooky or petty theft; consistent minor difficulties with school work, mood changes of brief 
duration; fears and anxieties which do not lead to gross avoidance behaviour; self doubts). Has some meaningful 
interpersonal relationships. Most people who do not know the child well would not consider him/her deviant but 
those who do know him/her well might express concern. 
  
60-51   
Variable functioning with sporadic difficulties or symptoms in several but not all social areas. Disturbance would 
be apparent to those who encounter the child in a dysfunctional setting or time but not those who see the child in 
other settings. 
  
50-41  
Moderate degree of interference in functioning in most social areas or severe impairment of functioning in one 
area, such as might result from, for example, suicidal preoccupations and ruminations, school refusal and other 
forms of anxiety, obsessive rituals, major conversion symptoms, frequent anxiety attacks, frequent episodes of 
aggressive or other antisocial behaviour with some preservation of meaningful social relationships. 
  
40-31   
Major impairment in functioning in several areas and unable to function in one of these areas, ie, disturbed at 
home, at school, with peers, or in the society at large, eg, persistent aggression without clear instigation; markedly 
withdrawn and isolated behaviour due to either mood or thought disturbance, suicidal attempts with clear lethal 
intent. Such children are likely to require special schooling and/or hospitalization or withdrawal from school (but 
this is not a sufficient criterion for inclusion in this category). 
  
30-21   
Unable to function in almost all areas, eg, stays at home, in ward or in bed all day without taking part in social 
activities OR severe impairment in reality testing OR serious impairment in communication (eg, sometimes 
incoherent or inappropriate). 
  
20-11   
Needs considerable supervision to prevent hurting other or self, eg, frequently violent, repeated suicide attempts 
OR to maintain personal hygiene OR gross impairment in all forms of communication, eg, severe abnormalities in 
verbal and gestural communication, marked social aloofness, stupor, etc. 
  
10-1  
Needs constant supervision (24-hour care) due to severely aggressive or self-destructive behaviour or gross 
impairment in reality testing, communication, cognition, affect, or personal hygiene. 
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